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Summary 
 
 
Plectin, a multi-domain protein of extraordinary large size, is known to connect 
cytoskeletal filament systems. Furthermore, plectin is supposed to be a scaf-
folding platform for signalling molecules. In this thesis plectin’s eventual role in 
regulating endothelial cell (EC) function was investigated.  
Two different endothelial cell lines were used for analysis. Briefly, cells de-
rived from kidneys and lungs of plectin+/+ and plectin-/- mice were immortalized 
by polyoma middle T infection. The middle T antigene causes cell proliferation 
and specifically ECs gain proliferation advantage over other cells (Williams et 
al., 1988). Thorough characterization of these cell lines revealed that EC 
markers are expressed in both plectin+/+ and plectin-/- ECs, although the total 
amounts of eNOS, caveolin and VE-cadherin are reduced in plectin-/- ECs. 
Data obtained from cell fractionation experiments showed that caveolin, eNOS 
and VE-cadherin are increased in membrane fractions of plectin-/- cells com-
pared plectin+/+ ECs at the expense of the cytoskeleton fractions.  
Measurement of extracellular nitric oxide (NO) demonstrated that plectin-/- 
ECs produce less NO compared to plectin+/+ ECs. Moreover, plectin-/- cells 
show reduced levels of total eNOS and reduced activity of eNOS. 
Mechanical stimuli like shear stress resulting from blood pressure and flow 
modulate functions of ECs by activating mechano-sensors on the cell mem-
brane. These in turn activate different signalling pathways modulating the acti-
vation state and the expression of different proteins (Chien, 2006). Shear- 
stressed plectin+/+ and plectin-/- ECs were analysed by immunofluorescence 
microscopy and immunoblotting. In response to fluid shear stress an upregula-
tion of eNOS and caveolin was observed in both plectin+/+ and plectin-/- ECs, 
although to a lesser extent in plectin-/- cells. Furthermore, shear stress-induced 
VE-cadherin cluster formation was significantly reduced in plectin-/- compared 
to plectin+/+ ECs. Based on these data, it is suggested that in ECs plectin plays 
a major role as a regulator of EC key molecules like eNOS and VE-cadherin. 
Furthermore, an eventual involvement of plectin in sensing and / or responding 
to fluid shear stress was observed. 
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Zusammenfassung 
 
 
Plectin ist ein außergewöhnlich großes Protein mit vielen Bindungsdomänen, 
welches die Cytoskelettfilamentsysteme miteinander verbindet. Weiters stellt 
Plectin eine Plattform für Signalmoleküle dar. Im Zuge dieser Diplomarbeit 
wurde die Rolle von Plectin in Endothelzellen näher betrachtet. 
Zwei unterschiedliche Endothelzelllinien wurden für die durchgeführten 
Experimente verwendet. Nieren- und Lungenzellen von wildtyp Plectin+/+ und 
knock-out Plectin-/- Mäusen wurden mittels Polyoma middle T Infektion immor-
talisiert. Das middle T Antigen verursacht Zellproliferation und bewirkt einen 
Wachtstumsvorteil von Endothelzellen gegenüber anderen Zelltypen (Williams 
et al., 1988). Eine genaue Charakterisierung dieser Zelllinien ergab, dass En-
dothelzell-spezifische Markerproteine in Plectin+/+ und Plectin-/- Zellen expri-
miert werden, jedoch wurden reduzierte Mengen von eNOS, Caveolin und VE-
Cadherin in Plectin-/-  Zellen gefunden. Zellfraktionierungen zeigten, dass Ca-
veolin, eNOS und VE-Cadherin in Plectin-/- Zellen in der Membranfraktion an-
gehäuft sind, während sie in der Cytoskelettfraktion reduziert sind. 
Messungen von extrazellulärem Stickstoffoxid (NO) zeigten, dass Plectin-/- 
Endothelzellen weniger NO produzieren als Plectin+/+ Zellen. Weiters, wurden 
in Plectin-/- Zellen reduzierte Mengen von Gesamt-eNOS und eine verringerte 
Aktivität von eNOS nachgewiesen.  
Mechanische Reize, wie vom Blutfluss oder Blutdruck verursachte Scher-
kräfte, beeinflussen die Funktionen von Endothelzellen durch das Aktivieren 
von Mechanosensoren an der Zellmembran. Diese Mechanosensoren wieder-
um aktivieren verschiedene Signalwege, welche die Aktivierung und die Ex-
pression verschiedener Proteine beeinflussen (Chien, 2006). Plectin+/+ und 
Plectin-/- Zellen wurden Scherkräften ausgesetzt und durch Immunofluores-
zenzmikroskopie und Immunoblots analysiert. Eine erhöhte Expression von 
eNOS und Caveolin wurde als Antwort auf Schwerkräfte in Plectin+/+ und Plec-
tin-/- Zellen festgestellt, jedoch in geringerem Maße in Plectin-/- Zellen. Des 
Weiteren, war die Scherkraft-induzierte VE-Cadherin Clusterbildung in Plectin-/- 
im Vergleich zu Plectin+/+ Zellen stark reduziert. 
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Diese Daten weisen darauf hin, dass Plectin, durch die Regulation von En-
dothelzell-spezifischen Molekülen, wie eNOS und VE-Cadherin eine wichtige 
Rolle in Endothelzellen spielt. Weiters, wurde eine eventuelle Beteiligung von 
Plectin an der Erkennung und / oder an der Antwort auf Scherkräfte in Endo-
thelzellen beobachtet.  
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1. Introduction 
 
 
1.1. The Cytoskeleton 
 
The cytoskeleton is a dynamic three-dimensional network which spans the cy-
toplasm. A vast variety of cell functions is based on this organized filament sys-
tem. The cytoskeleton is essential for maintenance of cell shape, cell orienta-
tion and cell polarity as well as for migration and signal transduction. It is in-
volved in fundamental cell mechanics like mitosis and cytokinesis. The intracel-
lular transport, organelle motility and many other processes such as phagocy-
tosis and endocytosis are dependent on this filament network. There are three 
types of filament systems: actin filaments, intermediate filaments (IFs) and mi-
crotubules. 
 
1.1.1. Actin filaments 
 
Actin filaments, also termed F- (filamentous) actin or microfilaments, are two-
stranded α-helical structures. Those flexible polymers are composed of mono-
meric actin proteins, called G- (globular) actin and have a diameter of 5 – 9 
nm. Although actin filaments are expressed throughout the cell they are found 
at the cell cortex with the highest density. They can form different types of cell 
surface projections such as microvilli, filopodia and lamellipodia. The actin 
cytoskeleton is found in nearly all types of eukaryotic cells and plays a sig-
nificant role in a variety of cellular mechanisms like providing mechanical 
strength, spatial organization of the cytoplasm, transmitting internal stresses 
and signals. Actin filaments are interacting with various proteins like profilin 
(regulating actin filament polymerization), filamin, α-actinin and fimbrin (fila-
ment cross-linking), or proteins like tropomyosin and cofilin that are responsible 
for filament stabilization and destabilization, respectively. By providing a struc-
tural framework, the actin skeleton contributes to cell-cell (tight junctions, ad-
herens junctions) and to cell-matrix (focal adhesions) junctions. Tight junctions 
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(TJs) formed by claudins, occludin and zonula occludens (ZO) family members 
serve as permeability barriers. ZO-2 and ZO-3 proteins as well as occuldin in-
teract directly with actin. Adherens junctions (AJs) are formed between two 
neighboring cells and help to maintain tissue integrity. Cadherins constitute the 
major adhesive component of AJs and are connected to the actin cytoskeleton 
via p120, α- and ß-catenins. Focal adhesions (FAs) allow cells to bind to the 
extracellular matrix via integrins. The intracellular part of integrins is connected 
to the actin cytoskleton by vinculin, α-actinin, talin or filamin. 
 
1.1.2. Intermediate filaments (IFs) 
  
IFs have a diameter of 10 nm and are composed of IF subunits which are α-
helical rods that assemble to rope-like structures. IFs have a central α-helical 
rod domain flanked by globular amino and carboxylic acid termini. IFs are 
composed of monomer units which form a coiled-coil dimer that self-associates 
in an anti-parallel arrangement to build up a staggered tetramer. Tetramer units 
pack together to form a sheet of eight parallel protofilaments that are twisted 
into a rope-like filament. The helical rod domain is highly conserved in different 
isoforms, whereas the globular termini differ.  
There are various families of IFs, also termed IF proteins that are ex-
pressed in a tissue specific manner. One can distinguish between four major 
types of IF proteins in vertebrate cells:  
Type I: Acidic type of epithelial keratins  
Type II: Neutral type of epithelial keratins 
Type III: Vimentin like IFs:  
• Vimentin which is found in many cells of mesenchymal origin 
• Desmin which is expressed in muscle cells 
• Glial fibrillary acidic proteins (GFAP) which is found in glial cells  
Type IV: Neurofilament proteins (NF-L, NF-M, NF-H) which are expressed in 
neurons. 
Type V: Nuclear lamins (Lamins A, B, C) which are involved in the formation 
of the nuclear lamina that governs the shape of the nucleus. 
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IFs play an important role in both structural and functional elements of the cy-
toskeleton. Those highly viscoelastic filaments function as tension-bearing 
elements maintaining cell shape and rigidity of several organelles, including the 
nucleus. The IF network contributes to cell-cell (desmosomes) and cell-matrix 
(hemidesmosomes) junctions. Desmosomes are formed by the connection of 
cadherin family members (desmoglein, desmocollin) of neighboring cells. The 
intracellular part of cadherins is connected to the IF cytoskeleton by plakoglo-
bin and desmoplakin (DP). Hemidesmosomes connect integrins of cells with 
the basal lamina. The intracellular part of integrins is bound via plectin or BP 
230 to the IF cytoskeleton. ECs form unique junctions to capillaries, called the 
complexus adherens junctions (Schmelz et al., 1993). Within these EC specific 
junctions DP links VE-cadherin to the vimentin intermediate filament network 
through one of two intermediary armadillo proteins, p0071 (Calkins et al., 
2003), or plakoglobin (Venkiteswaran et al., 2002).  
These proteins that connect IFs to each other or to other components, 
thereby determining the shape of IF networks are called intermediate filament 
associated proteins (IFAPs). Several other IFAPs like fillagrin which is associ-
ated with to keratin fibers in epidermal cells or the best characterized IFAP 
plectin, have been identiefied to date.  
 
1.1.3. Microtubules (MTs) 
 
Microtubules are long hollow cylinders with a diameter of 25 nm that are in-
volved in many cellular processes like mitosis, cytokinesis and vesicular trans-
port. A microtubule is built from 13 protofilaments, each composed of tubulin 
subunits. Tubulin itself is formed of two globular proteins (α-tubulin, β-tubulin). 
The designated minus end of the microtubule is always connected with a 
MTOC (microtubule organizing centers) also called the centrosome, from 
which the nucleation of microtubules is launched. Microtubules are interacting 
with proteins called microtubule associated proteins (MAPs). High molecular 
weight proteins (200 – 300 kDa) and tau- proteins (40 – 60 kDa) are stabilizing 
microtubules against depolymerization. Kinesins and dyneins are responsible 
for the transport of vesicles and organelles along the microtubules. 
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1.2. Cytolinker proteins / Plakin family 
 
Cytoskeletal networks cooperate to perform many of their functions. Therefore, 
connector proteins are needed to crosslink cytoskeleton elements to each 
other. These connector proteins so called cytolinkers or plakins are a group of 
large (> 200 kDa) proteins that are able to interact with cytoskeleton filament 
systems and/or junctional complexes. Seven plakin family members have been 
identified so far: desmoplakin, bullous pemphigoid antigen 1 (BPAG1), micro-
tubule-actin crosslinking factor (MACF), envoplakin, periplakin, epiplakin and 
plectin. The members of the plakin family are defined by the presence of a 
plakin domain or a plakin repeat domain. Actin-binding domain (ABD), coiled-
coil rod domain, spectin-repeat containing rod and microtubule-binding domain 
are common in plakins but are not obligatory (Leung et al., 2002) (Fig. 1). 
Plakin genes often encode differentially expressed splice forms (Yang et al., 
1996). These proteins are often affected by autoimmune and inherited dis-
eases that cause tissue fragility and skin blistering (Leung et al., 2002). 
The most multifaceted plakin family member is plectin which is discussed 
in the following chapter. 
The desmoplakin gene encodes two alternatively spliced isoforms (DPI, 
DPII) that both bind via their carboxyl terminus to IFs and connect them with 
desmosomes (Green et al., 1989; Stappenbeck et al., 1993). Desmosomes are 
cell-cell adhesion junctions that are abundantly expressed in tissues that expe-
rience mechanical stress. Therefore, desmoplakin plays an important role in 
maintaining cellular strength and integrity (Green et al., 2000).  
Bullous pemphigoid antigen 1 (BPAG1) has four known isoforms (BPAG1-
a, BPAG1-b, BPAG-1e, BPAG1-n) that exhibit a distinct tissue distribution. 
These isoforms also originate from one gene which is alternatively spliced at 
the 5’ terminus. BPAG-1b expression is restricted to the heart and the skeletal 
muscles. (Leung et al, 2001). The two neuronal splice products of BPAG1 
gene, BPAG1-a and BPAG1-n (also called dystonin) are expressed especially 
in the central nervous system and have the potential to link actin and IF net-
works (Yang et al., 1996). BPAG-1e is expressed at high levels in basal epithe-
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lial and muscle cells and links hemidesmosomes to keratin IFs (Guo et al., 
1995).  
 
 
Fig. 1. Schematic diagram of plakin family members. Seven types of functional domains can be 
found in plakins: actin-binding domain (ABD), plakin domain, coiled - coil rod domain, 
plakin-repeat domain, spectrin-repeat-containing rod domain, Gas2-related (GAR) do-
main and glycine-serine-arginine (GSR) domain (modified from Leung et al., 2002).  
 
Microtubule actin cross-linking factor (MACF) also called ACF7 can bind 
via its amino-terminal ABD to actin. Furthermore, it is bound to microtubules 
via its carboxyl-terminus, and has the ability to connect both filament systems 
(Leung et al., 1999; Karakesisoglou et al., 2000). In situ hybridisation revealed 
that MACF expression is found throughout the mouse embryo with significantly 
higher expression levels in the nervous system (Leung et al., 1999). 
Envoplakin and periplakin are closely related members of the plakin family 
that are present in complex epithelial tissues like stratified squamous epithelia, 
mammary gland and bladder, but they can also be found in desmosomes 
(Ruhrberg et al., 1997; Määttä et al., 2000). Although both proteins share the 
characteristic plakin domain structure, their C-terminal domains are smaller 
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than those of the other plakins. Envoplakin and periplakin like no other plakin 
family members, have the potential to heterodimerize (Ruhrberg et al., 1997). 
Epiplakin has an atypical plakin structure because of the missing plakin- 
and coiled – coil rod domain (Fujiwara et al., 1996). Epiplakin has 16 domains 
homologous to the B domain in the COOH-terminal region of desmoplakin. It is 
expressed in a wide range of tissues like brain, epidermis salivary glands and 
liver. (Fujiwara et al., 2001) 
 
 
1.3. Plectin – a prototype cytolinker 
 
Plectin is a versatile cytolinker of extraordinary large size (Mr < 500.000) per-
forming a vast variety of functions (for review see Wiche, 1998). It was first 
identified in high salt/Triton X-100 extracts of rat glioma C6 cells where it asso-
ciated with IFs (Pytela and Wiche, 1980; Wiche and Baker, 1982). It was 
shown using immunofluorescence, immunoelectron microscopy as well as im-
munoblotting that plectin is expressed in many different mammalian cell types 
and tissues. The highest expression of plectin is found in muscle, stratified and 
simple epithelia as well as in cells forming the blood brain barrier. Depending 
on the cell type examined, plectin is localized throughout the cytoplasm, at at-
tachment sites for IFs, or at adherence-type junctions and codistributed with 
IFs and microtubules (Wiche et al., 1983; Wiche et al., 1984; Wiche, 1989). 
Furthermore, plectin colocalizes with actin filaments and focal contacts in cul-
tured fibroblast cells (Seifert et al., 1992). 
Electron microscopy (Foisner and Wiche, 1987) as well as sequencing of 
rat plectin cDNA (Wiche et al., 1991) revealed that plectin molecules are 
dumbbell-shaped 200 nm-long structures consisting of a central rod domain 
flanked by large globular domains (Fig. 2). A highly conserved ABD which con-
sists of calponin-homology (CH) domains, is found at the N-terminal domain of 
plectin (Goldsmith et al., 1997). This ABD is shared with a lot of actin binding 
proteins like spectrin, α-actinin and dystrophin. The signalling molecule phos-
phaditylinositol-4, 5-biphosphate (PIP2) that regulates plectin’s binding to actin, 
also binds to this ABD (Andrä et al., 1998). Furthermore, one or more binding 
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sites for integrin α6β4 are found at the N-terminal domain (Rezniczek et al., 
1998).  
The α-helical coiled-coil rod domain is encoded by exon 31 and spans over 
200 nm. The properties of the amino acid sequence indicate that plectin mole-
cules form homodimers via this rod domain. The extraordinary long rod domain 
allows the connection of two binding partners of plectin over long distances 
(Wiche et al., 1991). 
The C-terminal domain of plectin consists of six long tandem repeats and 
is encoded by the very large exon 32. These highly conserved repeats share a 
19 amino acid residue motif (Wiche et al., 1991). A binding site for vimentin 
and cytokeratins comprising 50 amino acid residues (Herrmann and Wiche, 
1986) (Steinböck et al., 2000) was mapped to a region between repeats 5 and 
6 of plectin’s GC domain (Nikolic et al., 1996). Plectin is phophorylated during 
M-phase of the cell cycle by p34cdc2 kinase at a unique site (threonine 4542) 
which is located in its repeat 6 region (Foisner et al., 1996). Another binding 
site for integrin α6β4 is found at the C-terminal domain (Rezniczek et al., 1998). 
Due to its tripartite molecular structure plectin has the ability to bind to a 
great variety of binding partners. Many of them have been identified so far al-
though their exact binding site is partially not known. The cytoskeletal proteins, 
MAP 1, MAP 2, α-spectin and fodrin (Herrmann and Wiche, 1986), as well as 
the hemidesmosomal β4 integrin (Rezniczek et al., 1998) and the desmosome-
associated protein desmoplakin (Eger et al., 1997) are known to interact with 
plectin. Plectin binding partners among the IF protein family are vimentin 
(Foisner et al., 1988), neurofilament proteins NF 210/160/70, glial fibrillary 
acidic protein (GFAP), certain skin cytokeratins (Steinböck et al., 2000), 
desmin (Reipert et al., 1999) and lamin B (Foisner et al., 1991). Several other 
interaction partners of plectin have been identified, including phosphokinases 
Ca2+/calmodulin-dependent kinase, protein kinase A and C but so far their 
binding sites at plectin are not known (Steinböck and Wiche, 1999).  
Due to plectin’s intracellular localization, its large set of binding partners 
and its extraordinary long rod domain, plectin was supposed to be a scaffolding 
platform for signalling molecules. It is known that plectin interacts with AMP-
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activated protein kinase (AMPK) (Gregor et al., 2006) as well as with Fer 
kinase (Lunter and Wiche, 2002) and regulates their enzymatic activites. 
 
Fig. 2. Schematic structure of plectin. Central rod domain (* indicate mutations) flanked by the 
globular terminal domains. ABD and binding site for integrin β4 are located at the globu-
lar amino-terminal (GN) domain. IF (vimentin, cytokeratin) and integrin β4 binding sites 
as well as a phosphorylation site for protein kinase p34cdc2 are found at the globular car-
boxy- (GC) domain. (Wiche, 1998) 
 
It is also involved in the reorganization of the actin cytoskeleton by influ-
encing Rho, Rac, and Cdc42 GTPases (Andrä et al., 1998). The hypothesis 
that plectin is a link between the cytoskeleton and signalling cascades was 
confirmed by the finding that plectin binds the receptor for activated C kinase 1 
(RACK 1) to the cytoskeleton and thereby influences protein kinase C (PKC) 
signalling (Osmanagic-Myers and Wiche, 2004). Furthermore, plectin is in-
volved in Erk-MAP kinase signalling and affects cellular stress response and 
migration (Osmanagic-Myers et al., 2006). 
Analysis of plectin cDNA from human (Liu et al., 1996), rat (Wiche et al., 
1991) and mouse (Andrä et al., 1997) revealed that plectin gene consists of 32 
exons extending over 32 kb of DNA. It is localized to the telomeric region of the 
long arm of chromosome 8 (8q24) (Liu et al., 1996; McLean et al., 1996). Al-
though alternatively splice products are found in some plakin family members, 
the complexity of 5’ transcripts from plectin gene was not expected. So far 16 
alternatively first plectin exons have been identified by screening a plectin-
primed cDNA library (Elliott et al., 1997) and RACE PCR analysis (Fuchs et al., 
1999). 11 of these first coding exons (1 – 1j) splice into the common down-
stream exon 2 (Fuchs et al., 1999). Two additional exons (2α and 3α) are 
spliced into the ABD and three non-coding exons precede exon 1c (Fig. 3).  
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Fig. 3. Schematic overview of plectin isoforms generated by alternative splicing at the 5’-end of 
the plectin gene. (Fuchs et al., 1999) 
 
Patients suffering from epidermolysis bullosa simplex (EBS) combined with 
muscular dystrophy (EBS-MD) lack expression of plectin (Gache et al., 1996; 
McLean et al., 1996). EBS-MD is an autosomal recessive disease character-
ized by severe skin blistering associated with late onset of muscular dystrophy 
and is some cases respiratory stridor, respiratory distress and urethral stricu-
tures (Mellerio et al., 1997; Dang et al., 1998). By now 22 different mutations in 
the plectin gene have been identified, most of them causing a frameshift or a 
premature stop codon in plectin mRNA. (Nakamura et al., 2004) 
An autosomal dominiant form of EBS, EBS-Ogna was mapped to the same 
telomeric region of chromosome 8 as the plectin gene. EBS-Ogna is a skin 
blistering disease resulting from a missense mutation in exon 31 of the plectin 
gene (Koss-Harnes et al., 2002).  
To investigate the relation between plectin and EBS-MD plectin deficient 
mice were generated. Homozygous plectin deficient mice showed severe skin 
blistering and abnormalities of muscle, a phenotype corresponding to that ob-
served in EBS-MD patients (Andrä et al., 1997).  
 
 
 
1.4. Plectin and endothelial cells 
 
The endothelium is a thin layer of cells that line the interior surface of blood 
vessels (Fig. 4). ECs are selective filters that regulate the passage of gases, 
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fluid and various molecules across their membranes. By secreting biochemical 
substances like nitric oxide (NO), reactive oxygen species (ROS) or glutathione 
ECs control the vascular homeostasis. Furthermore, these specialized cells 
play a role in regulating leukocyte, platelet and red cells functions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4. Schematic picture of arterial wall. Tunica intima comprises the endothelium, the associ-
ated connective tissue and beneath the internal elastic lamina. Tunica media is formed 
by circumferential smooth muscle, connective tissue and external elastic lamina. Tunica 
adventitia consists mainly of connective tissue fibers. 
 
In this diploma thesis the EC markers eNOS, VE-cadherin and van Willebrand 
factor were of particular interest.  
The endothelial nitiric oxide synthase (eNOS), also known as nitric oxide 
synthase 3 (NOS 3), is constitutively expressed in ECs and generates L-
citrulline and NO by oxidizing L-arginine (Wyatt et al., 2004). NO, the endothe-
lium-derived relaxing factor regulates vascular homeostasis and prevents for-
mation of athereosclerotic lesions (Harrison et al., 2006). 
Vascular endothelial (VE)-cadherin is a member of the cadherin family, a 
group of Ca2+-dependent cell-cell adhesion molecules (Venkiteswaran et al., 
2001). Cadherins are associated to microfilament network by a complex of β-
catenin, plakoglobins and α-catenin. This interaction of cadherins with the cy-
toskeleton is required for the formation and maintenance of the restrictive en-
dothelial monolayer (Iyer et al., 2003). VE-cadherin is important for tissue 
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morphogenesis, cell adhesion and intercellular junction assembly. It is known 
to play a role in regulation of their growth, survival, migration and proliferation 
(Venkiteswaran et al., 2001). Although VE-cadherin function is not essential for 
the assembly of a primitive capillary plexus (vasculogenesis), subsequent 
maturation, branching and remodelling (angiogenesis) is depending on endo-
thelial apoptosis regulated by VE-cadherin (Gory-Fauré et al., 1999).  
Another important molecule synthesized in ECs is van Willibrand factor 
(vWF). It is essential for the blood clotting reaction (haemostasis). vWf deficient 
patients suffer from pseudohaemophilia an inherited disease resulting in im-
paired blood clotting and therefore excessive internal or external bleedings 
(Sadler, 1998). 
 
An indication that plectin might play a role in the regulation of the vascular 
system and in the development of vascular diseases was given by patients suf-
fering from Epidermolysis bullosa acquisita (EBA). This subepidermal bullous 
autoimmune disease with autoantibodies against type VII collagen and plectin 
is characterized by erythematous macules, hypertension and angina pectoris 
(Buijsrogge et al., 2005). Interestingly, no bleedings have been reported in 
other EBS variants like Dowling Meara or the Knoeber subtype, resulting from 
a mutation in keratin 14 or 5, respectively (Coulombe et al., 2002). Although no 
abnormalities of the vascular system in EBS-MD patients have been reported 
so far plectin deficient mice develop severe skin blistering particularly at the 
upper and lower extremities often accompanied by bleedings. This type of 
bleeding might be an evidence for a perturbation of vascular system.  
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2. Materials and Methods 
 
 
2.1. Common buffers 
 
TE: 
Tris-HCl 10 mM 
EDTA 1 mM 
pH 8,0 
 
1 x PBS: 
NaCl 150 mM 
KH2PO4/Na2HPO4 10 mM 
pH 7,4 
 
PBS-T: 
PBS containing 0,05 % Tween-20 
 
 
2.2. Mammalian cell culture methods 
 
ECGS (Endothelial cell growth stimulant): 
Biomedical Technologies; Cat. no. BT-203 
50 mg were diluted in 10 ml PBS (5 mg/ml), aliquoted and freezed at -20 °C.  
 
Heparin Sodium: 
Sigma; Cat. no. H3393; 180 U/ml 
Heparin Sodium is diluted 1:250 to a final concentration of 25 mg/ml with PBS and stored at 
room temperature.  
 
DMEM (Dulbecco’s Modified Eagle’s Medium): 
DMEM  
FCS 10 % 
Penicillin/Streptomycin (P/S) 100 U/100 mg/ml 
L-Glutamin  2 mM 
 
Base Medium: 
DMEM 
HEPES 25 mM 
FCS 20 % 
P/S 100 U/100 mg/ml 
L-Glutamin 2 mM 
 
Complete Culture (CC) Medium: 
Base Medium  
Heparin Sodium  100 µg/ml 
ECGS 100 µg/ml 
Non essential amino acid (Invitrogen; Cat. no. 11140050) 1 mM 
Sodium pyruvate (Invitrogen; Cat. no. 11360-039) 1 mM 
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Trypsin/EDTA: 
Trypsin 500 mg/l 
EDTA (Na-salt) 0,2 % 
Sterilized by filtration. 
 
Gelatine coated dishes: 
For primary endothelial cells and DH-1 cells plates were coated with 2 % gelatine solution type 
B (Sigma; Cat. no. G-1393) supplemented with P/S (1:100). pT Endo cells were grown on 
dishes coated with 1 % gelatine solution type B (diluted in PBS) with the addition of 1:100 P/S. 
All dishes were coated with gelatine over night at 37°C and washed prior to usage with PBS. 
 
2.2.1. General instructions for different Endothelial cell (EC) lines 
 
Primary ECs isolated from either lungs or kidneys of plectin+/+ and plectin-/- 
mice (line 29)  
DH-1 ECs isolated from lungs of plectin+/+ and plectin-/- mice (line 29); immor-
talized by Polyoma middle T infection. In these mice the plectin gene was inac-
tivated by disruption of rod-encoding exon 31 (Andrä et al., 1997).  
pT Endo ECs isolated from kidneys of plectin+/+ and plectin-/- mice (line 29); 
immortalized by Polyoma middle T infection; generated in 1999 by K. Andrä. 
 
Primary ECs and DH-1 ECs were treated the same way. Centrifugation was 
always preformed at 1 700 rpm using Heraeus Megafuge. For cultivation CC 
medium was used, while using base medium for short periods of incubation. 
pT Endo cells were centrifuged at 1 000 rpm using Heraeus Megafuge and cul-
tivated in DMEM supplemented with 10 % FCS, 100 U/100 mg/ml P/S an 2 mM 
L-Glu. 
 
2.2.2. Thawing of cells 
 
After thawing cells in a 37°C warm-waterbath these were transferred into a 15 
ml tube and mixed with 9 ml of the appropriate medium. Cells were harvested 
by centrifugation for 3 min using Heraeus Megafuge. Pellet was resuspended 
in adequate medium and cells were seeded on gelatine-coated plates. Cells 
were cultivated at 37 °C and 5 % CO2.  
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2.2.3. Freezing of cells 
 
Cells were washed with PBS, trypsinised and centrifuged for 3 min using Her-
aeus Megafuge. The pellet was dissolved in 90 % FCS + 10 % DMSO. After 
transfer into cryotubes cells were kept at -80°C and, after at least 24 h, stored 
in liquid nitrogen. 
 
2.2.4. Passaging of cells 
 
When cells got confluent they were washed with PBS. After incubation with 
Trypsin/EDTA for 3 – 10 min at 37°C detached cells were mixed with appropri-
ate medium and collected by centrifugation for 3 min using Heraeus Megafuge. 
The pellet was dissolved in adequate medium and cells were seeded in the 
desired ratio on gelatine-coated plates.  
 
2.2.5. Isolation of primary endothelial cells (ECs) 
 
Washing buffer: 
PBS without Ca2+ and Mg2+ 
BSA 0,1 % 
EDTA 2 mM 
pH 7,4 
 
1. Precoating of anti-rat IgG Dynal beads: 
 
An aliquot of Dynal M-450 sheep anti-rat immunoglobulin IgG magnetic beads 
(Dynal, Cat.no. 110.35) was resuspended in 1 ml of washing buffer and placed 
on the magnetic separator (Dynal MPC-S) for 1 min. Supernatant was removed 
and this washing step was repeated 3 times. After the last washing step beads 
were resuspended in the original volume of washing buffer. 2,5 µg of purified 
rat anti-mouse PECAM-1 (CD31, clone MEC13,3; 0,5 mg/ml concentration, 
Pharmingen; Cat. no. 557355) or rat anti-mouse ICAM-2 (CD102, clone 3C4; 
0,5 mg/ml concentration, Pharmingen; Cat. no. 553326) were added for every 
50 µl of magnetic beads and rotated end over end at 4°C overnight. On the
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next day washing was repeated 4 times. After resuspending the beads in the 
original volume of washing buffer they were stored at 4°C.  
 
2. Disscetion: 
 
The 1 - 2 day old mice were decapitated and the legs were pinned down with 
needles. The abdomen was sprayed with 70 % ethanol. Starting form the ante-
rior part, the abdomen was opened by scissors. Lungs and kidneys were ex-
cised with forceps and scissors. Organs dissected were placed into a 50 ml 
tube containing 10 ml of ice-cold base medium. 
 
3. Tissue dissociation: 
 
Collagenase solution: 
Hank’s Balanced Salt Solution (HBSS, Invitrogen; Cat. no. 14025050) containing 0,2 mg/ml 
(180 – 200 U/ml) collagenase type I (Gibco; Cat. no. 17100). 
 
Tissues were finely minced by two scalpels, transferred quantitatively into a 50 
ml tube containing 5 ml pre-warmed collagenase solution (diluted 1:10 with 
HBSS) and incubated for 45 min at 37°C with gentle agitation. The duration of 
collagenase treatment was varied due to different strengths of collagenase 
from charge to charge. The cell suspension was pressed about 10 times 
through 27G needle by a 5 ml syringe and filtered through a 70 µm nylon filter. 
The filter was rinsed with 10 ml of base medium. Cells were pellet by centrifu-
gation at 400 g for 8 min at 4°C. The supernatant was discarded and the pellet 
was resuspended in 2 ml of pre-warmed CC medium.  
 
4. Primary sorting of primary ECs by PECAM-1 
 
After one day of cultivation cells were washed up to 6 times with PBS to re-
move non-adherent cells and new CC medium was added. Upon reaching con-
fluency cells were trypsinised and resuspended in 400 µl base medium. The 
cells were transferred into a 500 µl Eppendorf tube containing 8 µl of PECAM-1 
coated Dynal beads. Suspension was rotated end over end at 4°C for 40 min. 
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The cell suspension was mixed with 1 ml of washing buffer, placed on the 
magnetic seperator for 2 min and supernatant was discarded. This washing 
step was repeated 3 times to remove unbound cells. After the last washing 
step cells were resuspended in 2 ml CC medium and seeded on a 3,5 cm gela-
tine-coated dish. The next day adherent cells were once rinsed with PBS and 2 
ml of CC medium were added. 
 
5. Second sorting of primary ECs by ICAM-2 
 
To improve purity primary cells were sorted a second time (second immuno-
bead isolation) at 80 to 90 % confluency (about 7 days after isolation), although 
it has to be mentioned that the efficiency of this sorting step was very low. 
Medium was removed and cells were washed two times with PBS before 
trypsinisation (3 min at 37°C). Detached cells were transferred into a 15 ml 
tube containing base medium (2x amount of trypsin added). After centrifugation 
at 400 g for 3 min cells were resuspended in 400 µl base medium and trans-
ferred into a 500 µl Eppendorf tube. 8 – 10 µl ICAM-2-coated beads were 
added and cells were rotated end over end for 20 min at 4°C. After this incuba-
tion step the cell suspension was mixed with 1 ml of washing buffer, placed on 
the magnetic seperator for 2 min and supernatant was discarded. This washing 
step was repeated 3 times. After the last washing cells were resuspended in 2 
ml CC medium and seeded on a 3,5 cm gelatine-coated dish. The next day 
adherent cells were once washed with PBS and 2 ml of CC medium were 
added. 
 
2.2.6. Immortalization of Endothelial Cells by Polyoma middle T Infec-
tion 
 
Collagenase Solution: 0,2 mg/ml (180 – 200 U/ml) Collagenase type I 
(Gibco; Cat. no. 17100) in HBSS 
 
G 418 Sulphate: 800 µg/ml in ddH20 (Gibco; Cat. No. 11811-064) 
 
Polybrene: Hexadimethrinbromide (Fluka; Cat. no. 52495) in ddH20 
 
Cells were isolated from 1-day old mice (line 29) by following procedure: 
  30 
 
 
 
Lungs and kidneys got dissected and were kept in 10 ml base medium on ice. 
The organs got minced finely by two scalpels and digested in 5 ml collagenase 
solution for 45 min at 37°C. After centrifugation for 8 min at 1 700 rpm 
(Hereaus centrifuge) the pellet was resuspended in 2 ml CC medium and 
plated onto a 3,5 cm gelatine-coated dish. The same day the virus producing 
cells (GP+E-86) were splitted to guarantee a high titer of virus particles in the 
supernatant. 
On the second day of cultivation cells were washed 5 times with PBS to 
get rid of non-adherent cells and new CC medium was added.  
When cells reached a confluency of 50 – 70 % virus transfection was 
started: Virus particle containing supernatant of GP+E-86 and CC medium 
were mixed 1:1 and 8 µg/ml polybrene was added. This solution was filtered 
through a 0,45 µm Nylon filter. The cells were incubated with this mixture at 
37°C and 5 % CO2. After 4 h the medium was discarded and new CC medium 
(+ 800 µg/ml G 418) was added. This virus infection was repeated at least 3 
times every 24 h. 
After infection periods the medium (CC medium + G418) was changed 
every 3 to 4 days. After 1 or 2 weeks groups of ECs appear while other cells 
die. ECs can easily be distinguished from other cells by their typical cobble-
stone morphology. After reaching a relatively high concentration of ECs (after 
2-3 weeks), cells were sorted by PECAM-1 sorting and a high purity EC culture 
was obtained. Addition of G 418 to the CC medium was performed for at least 
1 month. 
 
2.2.7. Virus producing cells (GP+E-86) 
 
We got this cell line as a kind gift of the group of Wagner Erwin (Institute of mo-
lecular pathology). 
 
Media: DMEM supplemented with 10 % FCS, 100 U/100 mg/ml P/S, 2mM L-Glu 
 
Handling with this virus producing fibroblast cell line was always performed in a 
special retroviral hood. Thawing, freezing and passaging of cells were exe-
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cuted like in basic protocol by taking care of the standard rules for working with 
retroviruses (see above). Cells were cultivated in 1 % gelatine-coated culture 
flasks.  
 
2.2.8. Endothelial cell transfection with FuGENE 
 
DMEM supplemented 10 % FCS, 100 U/100 mg/ml P/S, 2mM L-Glu or CC Medium (without 
heparin) 
DMEM 
 
Cells were seeded on 6 well dishes or 3,5 cm dishes. After reaching a conflu-
cency of 50 – 70 % transfection was started. 
DMEM was pipetted in a 15 ml Falcon tube and FuGENE reagent was di-
rectly added to the medium avoiding contact with the walls of the tube. After 
mixing carefully Plasmid DNA (1 µg/µl) was added followed by mixing and in-
cubation for 30 min at room temperature. Meanwhile the medium was aspi-
rated and fresh DMEM supplemented with 10 % FCS, 100 U/100 mg/ml P/S 
and 2mM L-Glu was added. After adding 100 µl DMEM the transfection mix 
was pipetted slowly on the cells.   
The next day new DMEM supplemented with 10 % FCS, 100 U/100 mg/ml 
P/S and 2mM L-Glu was added to the dishes to get a final volume of 2 ml or 5 
ml per 3,5 cm or 6 cm dish, respectively. 
24-48 h after transfection cells were fixed by ice-cold methanol for 90 sec 
and immunostained. 
 
For transfection of DH-1 cells, cells were grown and transfected in CC medium 
(without heparin). 
 
Protocol for 3,5 cm dish: 
- 67 µl DMEM 
- 2.7 µl FuGENE 
- 1.7 µg DNA  
- 100 µl DMEM 
- 833 µl DMEM + 10 % FCS + P/S + L-Glu or CC-medium (without heparin) 
 
 
Protocol for 6 cm dish: 
- 200 µl DMEM 
- 8 µl FuGENE 
- 5 µg DNA  
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- 300 µl DMEM 
- 2.5 ml DMEM + 10 % FCS + P/S + L-Glu or CC-medium (without heparin) 
 
 
2.3. Protein methods 
 
2.3.1. Lysis of cells 
 
2x Sample buffer: 
Tris-HCl, pH 6,8 50 mM 
DTT 100 mM 
SDS 2 % 
Bromphenol blue 0,1 % 
Glycerol 10 % 
 
Cells were rinsed with pre-warmed PBS, 150 µl 2x Sample buffer per 3,5 cm 
dish were added and cells were scarped off with a cell scraper. Lysates were 
pressed through a 27G needle to get a homogenous solution, heated at 95°C 
for 3 min and stored at -20°C for short periods or at -80°C for longer intervalls. 
 
2.3.2. SDS-polyacrylamide gel electrophoresis (PAGE) 
 
Running buffer: 
Tris 25 mM 
Glycine 250 mM 
SDS 0,1 % 
 
30 % Acrylamide mix: 
Acrylamide 29 g 
Bis-Acrylamide 1 g 
ddH20 to 100 ml 
 
Separating gel was prepared and overlaid with 96 % ethanol. After polymeriza-
tion the alcohol was discarded and the stacking gel was poured. Samples 
mixed with 2x Sample buffer were heated to 95°C for 3 min before loading onto 
the gel. The gel apparatus was filled with running buffer and gels were run at 
20 mA / gel until the marker front reached the bottom of the gel. 
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 Separating gel 
 8 %  10 % 12 % 
Stacking gel 
5 % 
ddH2O 4,6 4,0 3,3 1,4 
30 % Acrylamide mix 2,7 3,3 4,0 0,33 
1,5 M Tris-HCl (pH 8,8) 2,7 2,5 2,5  
1,5 M Tris-HCl (pH 6,8)    0,25 
10 % SDS 0,1 0,1 0,1 0,02 
10 % APS 0,1 0,1 0,1 0,02 
TEMED 0,006 0,004 0,004 0,002 
Tab. 1: Separating gel and Stacking gel solutions in ml (for 10 ml and 2 ml, respectively) 
 
2.3.3. Coomassie staining 
 
Staining solution. 
Coomassie R-250 0,4 % 
Acetic acid 10 % 
Methanol 45 % 
 
Destaining solution: 
Acetic acid 10 % 
Methanol 30 % 
 
Polyacrylamide gels were incubated for 30 min in staining solution, followed by 
incubation in destaining solution for 1-2 h (changing the solution every 30 min) 
until the bands became visible. Gels were dried in the vacuum drier for 2 h at 
80°C or scanned and quantified. 
 
2.3.4. Ponceau S staining 
 
Ponceau S solution: 
Ponceau S 0,1 % 
Acetic acid 1 % 
 
To perform a reversible staining of proteins, nitrocellulose membranes were 
stained with Ponceau S solution for 5 min at room temperature and washed 
with ddH2O until the bands became visible. After photographing membranes 
were completely destained by incubation in PBS-T for 5 – 10 min. 
 
2.3.5. Immunoblotting 
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Transfer buffer (10x): 
Tris 0,48 M 
Gylcine 0,4 M 
SDS 0,01 % 
 
Blocking solution: 
5 % non-fat dry milk powder or 4 % BSA in PBS-T 
 
Proteins were separated by SDS-PAGE (see above). The polyacrylamide gel 
was laid on a nitrocellulose membrane (Schleicher & Scheull). This sandwich 
was placed between 3MM Whatman filter papers and sponges and was fixed 
in blotting frames. Transfer was performed in a BioRad Mini Protean II blotting 
chamber, filled with transfer buffer, over night at 4°C with 25 V. After transfer 
proteins were detected by Ponceau S staining (see above). The membranes 
were rinsed with PBS-T, to destain them completely, followed by subsequent 
blocking of unspecific binding sites by blocking solution for 1 h at room tem-
perature. Antibodies were diluted in PBS-T with 0,02 % NaN3 and stored at 
4°C. After blocking primary antibodies were added for 1 h at room temperature 
or over night at 4°C. Membranes were washed 3 times for 10 min with PBS-T 
prior to the incubation with the secondary antibody for 1 h at room temperature. 
Membranes were washed 3 times for 10 min with PBS-T, incubated with HRP 
substrate solution (Super Signal West Pico Chemiluminescent Substrate 
Pierce; Cat. no. 34080) for 5 min and exposed to film (Fuji). 
 
Primary antibodies dilution 
mouse α actin 1: 200 
mouse α α-actinin 1: 1 000 
mouse α AKT 1: 200 
rabbit α caveolin 1: 2 500 
rabbit α eNOS 1: 500 
rat α ICAM 2 1: 500 
rabbit α integrin α5 1: 500 
rabbit α Phospho-Threonin eNOS 1: 2 500 
rabbit α Phospho-Serine eNOS 1: 2 500 
rabbit α Plectin (#9) 1: 3 000 
rabbit α Plectin Exon 1 1: 500 
rabbit α Plectin Exon 1a 1: 1 000 
rabbit α Plectin Exon 1c 1: 2 000 
rabbit α Plectin Exon 1f 1: 300 
mouse α Tubulin 1: 1 000 
rat α VE-cadherin  1: 500 
mouse α Vinuclin 1: 1 000 
rabbit α vWF 1: 100 
Tab. 2: Primary antibody solutions used for immunoblotting 
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Secondary antibodies dilution 
goat α mouse HRPO 1: 10 000 
goat α rabbit HRPO 1: 10 000 
goat α rat HRPO  1: 10 000 
Tab. 3: Secondary antibody solutions used for immunoblotting 
 
2.3.6. Quantification of Immunoblotting by Quantiscan software 
 
Bands were scanned and quantified using Quantiscan software. Only bands 
intensities falling in linear range were used for quantification. Tubulin or α-
actinin were used as loading control. The values obtained by the software were 
plotted against loading control values to obtain absolute values independent on 
cell confluency. 
 
2.3.7. Cell fractionation (digitonin – based method)  
 
Digitonin buffer: 
Digitonin 0,01 %  
PIPES 10 mM 
Succrose 300 mM 
NaCl 100 mM 
MgCl2 3 mM 
EDTA 5 mM 
DTT 0,2 mM 
Na3VO4 1 mM 
pH 6,8 
 
Buffer 2: 
Triton X-100 0,5 % 
PIPES 10 mM 
Succrose 300mM 
NaCl 100 mM 
MgCl2 3 mM 
EDTA 3 mM 
DTT 0,2 mM 
pH 7,4 
 
To reach a confluency of 80 – 90 % after 1 day, 200*104 cells were seeded on 
a 10 cm dish. Next day medium was discarded and cells were washed with 
pre-warmed PBS. Cell culture dishes were placed on ice and cells were 
scraped off in ice-cold PBS (containing phosphatase inhibitor mix) with a cell 
scraper. Cells were transferred into a 50 ml tube. After centrifugation at 1.000 
rpm for 3 min with Hereaus centrifuge, the pellet was resuspended in 150 µl 
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digitonin buffer and rotated end over end for 10 min at 4°C. After centrifugation 
at 14 000 rpm for 1 min with Eppendorf centrifuge the supernatant (cytosolic 
fraction) was transferred into a Eppendorf tube containing 50 µl x Sample 
buffer, heated at 95°C for 3 min and stored at -20°C. The pellet was resus-
pended in 150 µl buffer 2 and rotated end over end for 20 min at 4°C. After 
centrifugation at 14 000 rpm for 1 min with Eppendorf centrifuge the super-
natant (membrane fraction) was transferred into a Eppendorf tube containing 
50 µl 6x Sample buffer, heated at 95°C for 3 min and stored at -20°C. The pel-
let (cytoskeleton fraction) was resuspended in 40 µl 8M urea and kept on ice 
for 30 min. After vortexing this fraction every 10 min 6 µl 6x Sample buffer was 
added, the mixture was heated at 95°C for 3 min and stored at -20°C.  
 
2.3.8. Immunofluorescence microscopy 
 
Blocking solution: 
2 % BSA + 0,02 % NaN3 
 
Mowiol: 
6 g glycerol and 2,4 g Mowiol (Hoechst) were incubated in 6 ml of ddH2O for 2 h. 12 ml of 0,2 
M Tris-HCl solution, pH 8,5 were added for 10 min, heated to 50°C and spun for 15 min. The 
supernatant was stored at -20°C. 
 
Cells were grown on gelatine-coated dishes or on gelatine coated coverslips. 
Cells were rinsed with pre-warmed PBS, fixed for 90 sec with ice-cold metha-
nol and washed three times with PBS and could be stored in PBS at 4°C. Un-
specific binding sites were blocked with blocking solution for 1 h at room tem-
perature. Cells were incubated for 1 h with primary antibodies, diluted in block-
ing solution. Prior to incubation with the secondary antibody cells were washed 
3 times with PBS for 10 min. Cells were incubated with fluorescence-labeled 
secondary antibody, diluted in PBS, for 1 h at room temperature in darkness. 
Cells were washed three times with PBS for 10 min and rinsed immediately 
with ddH2O before they were mounted with Mowiol. 
 
Primary antibodies dilution 
mouse α actin 1: 80 
rabbit α actin 1: 80 
rabbit α caveolin 1: 500 
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mouse α desmoplakin 1: 10 
rabbit α eNOS 1: 100 
rabbit α GFP 1: 700 
rat α integrinα6 1: 100 
mouse α plectin (10F6) 1: 100 
rabbit α plectin (#46) 1: 400 
mouse α tubulin 1: 500 
rat α VE-cadherin  1: 30 
goat α vimentin 1: 800 
mouse α vinculin 1: 300 
rabbit α vWF 1: 100 
Tab. 4: Primary antibodies used in immunofluorescence microscopy. 
 
Secondary antibodies dilution 
donkey α goat Alexa 1: 1 000 
donkey α goat Texas Red 1: 100 
donkey α mouse Cy 5 1: 800 
donkey α mouse RRX 1: 100 
donkey α rabbit Cy5 1: 300 
donkey α rat Cy2 1: 100  
donkey α rat Cy5 1: 300 
goat α mouse Alexa 1: 800 
goat α mouse Texas red 1: 200 
goat α rabbit Alexa 1: 1 000 
goat α rabbit Texas red 1: 100 
goat α rat Texas red  1: 200 
Tab. 5: Fluorescence-labeled secondary antibodies used in immunofluorescence microscopy. 
 
 
2.4. Measurement of NO release by 4,5-diaminofluorescein 
(DAF-2) application 
 
Measurement was performed by Christoph Schmidt (Department for Pharma-
kognosy, University Vienna) by following protocol. 
 
L-arginine stock solution:  
100 mM L-arginine in H2O  
 
A23187 stock solution: 
10 mM A23187 in DMSO; stored at -20°C  
 
DAF-2 stock solution: 
5 mM in DMSO, aliquoted and freezed at -80°C  
 
PBS+Ca2+: 
KH2PO4  1,47 mM 
Na2HPO4 • 7 H2O 9,57 mM 
NaCl  137,00 mM 
MgSO4 • 7 H2O  0,49 mM 
KCl  2,68 mM 
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CaCl2 • 2 H2O  0,90 mM 
 
CaCl2 was solved in 1 l and all other components in another 1 l H2O. Both solutions were care-
fully mixed and pH was adjusted to 7.4. The pH has to be strictly regarded since the fluores-
cence of the DAF derivatives is pH-dependent.  
 
2.4.1. Cell culture 
  
Cells were seeded in a density of 20 x 104 cells per well in 6-well plates. When 
cells were confluent they were stimulated by PMA 24 h before measurement.  
 
2.4.2. Preparation of the assay 
  
The incubator, the water bath and a drying chamber were warmed up to 37°C. 
PBS+Ca2+ (supplemented with 100 µM L-arginine) were prepared and warmed 
up. The A23187 stock solution was diluted 1:5 in DMSO. DAF-2 stock solution 
was diluted 1:250 in PBS+Ca2+ (supplemented with L-arginine) and kept on ice 
in a light-protected box until use. The fluorescein derivate 4,5-
diaminofluorescein (DAF-2) reacts with an oxidation product of NO reaction to 
DAF-2T, a highly fluorescent triazolofluoresein 
 
2.4.3. Assay performance 
  
All operations with DAF-2 were preformed in a darkened room. And samples 
are protected from light while being transported to the spectrofluorimeter. NO 
production was measured in untreated, PMA-treated and L-NAME-treated 
cells.  
 
Cell supernatant was removed and cells were washed twice in 1 ml 
PBS+Ca2+. Cells were incubated with 2 ml PBS+Ca2+ (supplemented with L-
arginine) for 5 min at 37°C to let them equilibrate with a defined concentration 
of L-arginine. 1 µl of the diluted A23187 solution and 10 µl of the diluted DAF-2 
solution were added.  Cells were incubated again for another 5 min at 37°C in 
darkness. NO released during this time will react with DAF-2 to DAF-2T. Cell 
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supernatants were transferred into 2 ml plastic caps quickly to assure that the 
reaction time for all samples will be the same. The fluorescence of cell super-
natants was measured in a standard cuvette at an excitation wavelength of 490 
nm and an emission wavelength at 515 nm. Wells without cells were measured 
in order to calculate the DAF-2 auto-fluorescence. 
 
 
2.5. DNA Methods 
 
2.5.1. Bacterial strain and growth medium  
 
Bacterial strain: 
E.coli strain XL-2 blue (recA1, endA1, gyrA96, thi-1, hsdR17, supE44, relA1, lac[F’proAB 
lacIqZΔM15Tn10 (tetR) Amy CamR] was used for cloning procedures. 
 
LB (luria broth):  
Bacto-tryptone 10 g 
Bacto-yeast extract 5 g 
NaCl 10 g 
 
The pH was adjusted to 7,0 with NaOH and ddH20 was added to a final volume 
of 1 000 ml. The medium was autoclaved (20 min at 121°C, liquid cycle). Ap-
propiated antibiotics (ampicillin: 100 µg/ml) were added to the medium after 
cooling down.  
To prepare plates, 15 g/l agar was added to the medium before autoclav-
ing after hardening, plates were stored at 4°C. 
 
2.5.2. Preparation of bacterial freezer stocks 
 
0,85 ml bacterial culture were mixed with 0,15 ml glycerol in a screw-cap stor-
age tube. After vortexing the stocks were frozen using liquid N2 and stored for 
longer time periods at -80°C. 
 
2.5.3. Preparation of KCM competent cells 
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TSS Solution: 
LB 75 ml 
PEG 3350 10 g 
DMSO 5 ml 
1 M MgSO4 10 ml 
1 M MgCl2 10 ml 
 
5 ml LB medium (add antibiotic if cells have antibiotic resistence) were inocu-
lated with a single E. coli colony and incubated overnight at 37°C and 220 rpm. 
1 ml of overnight culture was added to 100 ml LB medium (without antibiotic) 
and incubated at 37°C at 220 rpm until an OD600 of 0,5 – 0,6 was reached. At 
this point the flask was kept on ice for at least 20 min and cells were collected 
by centrifugation at 4 000 rpm for 10 min at 4°C. The bacterial pellet was re-
suspended in 5 ml of ice-cold TSS solution and incubated of ice for 15 min. 
The suspension was divided into 100 µl aliquots, which were quickly frozen in 
liquid N2 and stored at -80°C. 
 
2.5.4. Transformation of bacteria 
 
5x KCM: 
KCl 0,5 M 
CaCl2 0,15 M 
MgCl2 0,25 M 
sterile filtered, stored at 4°C 
 
Competent E. coli cells (prepared with KCM method) were thawed on ice. 1 -80 
µl of plasmid DNA were mixed with 20 µl 5x KCM and ddH20 were added to a 
final volume of 100 µl. 100 µl of the cell suspension were mixed with the DNA 
mixture and incubated for 20 minutes on ice. The suspension was heated for 5 
min to 37°C, 1 ml of pre-warmed LB medium was added and incubated for 40 
– 60 min at 37°C. The bacteria were plated on a selective medium and left to 
grow overnight at 37°C. 
 
2.5.5. Midi Preperation 
 
To perform a Midi preparation the Promega kit Pure Yield Plasmid Midiprep 
System (Promega; Cat. no. A2495) was used according to manufacturers in-
structions: 
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150 ml overnight culture were harvested by centrifugation for 10 min with 
5000 g. The supernatant was discarded and the cell pellet was resuspended in 
6 ml cell resuspension solution. 6 ml cell lysis solution was added and incu-
bated for 3 min. After adding 10 ml neutralization solution the pellet was mixed 
carefully and incubated for 3 min at room temperature. After centrifuation for 10 
min at 15 000 rpm the DNA was cleaned by a column system. The blue clear-
ing column was placed onto the white binding column and the cell lysate was 
added to the blue column. After starting vacuum pump and detaching the blue 
clearing column, 5 ml endotoxin removal wash and 20 ml column wash solution 
were sucked through the binding column. After 1 min the vacuum was turned 
off and the binding column was placed into a 50 ml Falcon tube. 600 µl nuce-
lase-free water were pipetted onto the column. After 5 min incubation the DNA 
was eluted by centrifugation at 2 000 g for 5 min. 
 
2.5.6. DNA Isolation from murine tails and toes 
 
Tail buffer: 
Tris-HCl pH 8,0 50 mM 
EDTA pH 8,0 100 mM 
NaCl 100 mM 
SDS 1 % 
 
To isolate DNA from 3 week-old mice, pieces of their tails were cut and follow-
ing protocol were used. To determine genotype of 10 day-old mice, their toes 
were used for DNA isolation but only half of the amounts denoted in following 
protocol were used.  
715 µl of tail buffer and 35 µl proteinase K (10 mg/ml) were added to each 
sample and shacked by thermomixer overnight at 55°C at level 10. (As toes of 
10 day-old mice get digested more quickly, 3 h of incubation were sufficient).  
After incubation, probes were shaked for 5 min at level 14 and 50 µl 5,5 M 
NaCl were added. Probes were reversed 3 times and shacked for 5 min at 
level 14. After centrifugation at 14 000 rpm for 10 min with Eppendorf Centri-
fuge the supernatant was transferred into new Eppendorf tubes containing 500 
µl isopropanol. DNA precipitated after reversing the samples about 50 times. 
By centrifugation at 14 000 rpm for 15 min with Eppendorf Centrifuge DNA got 
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pelleted. The supernatant was discarded and 1 ml of 70 % ethanol was added 
to the pellet. After centrifugation at 14 000 rpm for 10 min with Eppendorf Cen-
trifuge the alcohol was completely removed. The DNA pellet was dried for 30 
min and dissolved in 100 µl 10 mM Tris pH 8,0 by thermomixing at 37°C and 
level 9 overnight. The DNA was stored at 4°C. 
 
2.5.7. Polymerase Chain Reaction (PCR) genotyping 
 
To determine the genotype of mice from line 29 plectin rod PCR was per-
formed. DNA was isolated from tails or toes (see above). 
 
Reactions plectin rod PCR 
ddH20 16,25 µl 
5x PCR Buffer 5 µl 
dNTPs (10 mM each) 0,5 µl 
Primer (10 pmol/ µl) 0,5 µl mPE30/U 
0,5 µl mPIntr30/L 
0,5 µl Primer mPle6437L 
0,5 µl Neo 19 
Go TAQ Polymerase (Promega) 0,25 µl 
DNA template 1 µl 
Tab. 6: Plectin rod PCR 
Following PCR approach was preformed for plectin rod PCR: 
Cycles Temperature Duration 
1 x  94°C 5 min 
94°C 30 sec 
58°C 30 sec 
35 x  
72°C 2 min 
1 x  72°C 7 min 
1x 4°C Ad infinitum 
Tab. 7: PCR protocol for plectin rod PCR 
 
Primer 5’ to 3’ Sequences: 
 
mPE30/U CAGTGAGACCCTTCGCCGCATG 
mPIntr30/L GTGCTCACATGACACGGAAGGTAC 
Neo 19 CATTCAGGACATAGCGTTGG 
 
2.5.8. Agarose gel electrophoresis 
 
10x DNA sample buffer: 
Urea 4 M 
Saccharose 50 % (w/v) 
EDTA 1 mM 
Brompheol-blue 0,1 % (w/v) 
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50 x TAE: 
Tris-acetate 400 mM  
Na2EDTA⋅H20 20 mM 
pH 8,2 
 
0,8 – 1,8 % agarose gels were prepared and 8 µl ethidiumbromide were added 
before pouring the gels to visualized DNA under UV light. Samples were mixed 
with 1/10 vol. of 10x DNA sample buffer and DNA fragments were separated 
with 100 V.  
 
 
2.6. Flow Assays using parallel flow chamber 
 
Rectangular Flow Chamber (for standard microscope slide) 
Glycotech (Maryland, USA; Cat. no. 31-010) 
 
2.6.1. Cell cultivation 
 
Cells were cultured on a microscope slide coated with gelatine. The micro-
scope slide (Fig. 4C) was either put inside a 10 cm dish or a 10 x 10 cm cham-
ber and cells were grown to confluency. One day before flow stress assay was 
performed medium was changed to avoid detaching of cells. 
 
2.6.2. Flow chamber setup 
 
The incubator and media were warmed to 37°C 1 h prior to beginning flow as-
say.  
The flow system apparatus was assembled by following procedure: flow 
deck (Fig. 4A) and the chamber gasket (Fig. 4B) were connected by aligning 
the gasket to the flow deck and pressing the deck on top of the gasket. If static 
was a problem the flow deck was placed on an antistatic strip prior to installing 
gasket. The medium inlet and outlet as well as vacuum lines were connected 
to flow deck. The inlet reservoir was filled with media. The microscope slide 
was attached to the flow chamber by holding the deck inverted. A small bubble 
of media was placed on flow path area to avoid air bubbles in the system. Vac-
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A 
 
 
B 
 
 
C 
uum held the slide on the deck. Flow was initiated by connecting peristaltic 
pump to outlet of the flow chamber at a shear stress rate of 5 dynes/cm2 for 1 – 
24 h. 
 
 
 
 
 
 
 
 
 
Fig. 5. Schematic picture of flow chamber. (A) flow deck (B) chamber gasket (C) microscope 
slide with cultured ECs 
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3. Aims of thesis 
 
 
There are several hints for plectin`s involvement in the endothelium and the 
vascular system. Patients with mutations in basic functions of the plectin gene 
as well as plectin-deficient mice develop haemorrhagic blisters atypical for 
other skin blistering diseases. This suggests an altered structural integrity of 
the endothelium in the absence of plectin. VE-cadherin, a component of ad-
herens junctions, stabilizes EC cell junctions and maintains tissue integrity. 
Therefore, we wanted to investigate the intracellular distribution and protein 
levels of VE-cadherin in plectin+/+ and plectin-/- ECs.  
Furthermore, an involvement of plectin in regulating vascular function was 
indicated by treatment of ECs with the nitric oxide (NO) donor SNAP. This re-
sulted in a much more fragile vimentin filament system in plectin-/- cells com-
pared to plectin+/+ cells (Spurny, unpublished data). To further investigate this 
phenotype extracellular NO had to be examined as well as protein levels and 
localization of the NO producing enzyme eNOS had to be assesed. eNOS pri-
marily resides in small plasma membrane invaginations called caveolae. The 
major coat protein of caveolae, caveolin-1 is known to interact with eNOS. 
Hence, it was important to examine caveolin levels and localization in plectin+/+ 
and plectin-/- ECs.  
NO plays a central role in controlling vascular homeostasis and its produc-
tion is dramatically influenced by mechanical forces (like shear stress) imposed 
on the endothelium (Harrison et. al, 2006). Moreover, in response to fluid shear 
stress cytoskeletal protein and EC protein marker levels are known to be 
upregulated. After exposure to laminar shear stress plectin levels are also ele-
vated suggesting a role of plectin in strengthening the endothelial cytoskeleton 
in the face of biomechanical forces (Garcia-Cardena et. al, 2001). The major 
goal of this thesis was to investigate the effects of fluid shear stress on 
plectin+/+ and plectin-/- ECs. Eventual differences in protein levels and the local-
ization of eNOS, caveolin and VE-cadherin as well as cytoskeletal proteins 
were studied in detail by immunofluorescence microscopy and immunoblotting.  
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4. Results 
 
 
4.1. Characterization of pT Endo cell line 
 
Experiments described in this diploma thesis were performed on an endothelial 
cell line (pT Endo) originally generated by Andrä in 1999. Briefly, cells derived 
from kidneys of plectin+/+ and plectin-/- mice of line 29 and were immortalized 
by polyoma middle T infection (Williams et al., 1988). In these mice the plectin 
gene was inactivated by disruption of rod-encoding exon 31 (Andrä et al., 
1997). Those cell line, however, needed a thorough characterization. 
First, to confirm that pT Endo cells are indeed ECs and to check their purity, 
expression of EC markers was evaluated using immunoblotting (Fig. 6). To 
check if the eventual differences in expression pattern between plectin+/+ and 
plectin-/- cells were dependent on confluency state of cells, these were lysed 
after 1, 2 and 3 days of cultivation. On day 1 and 2 of cultivation cells had 
reached a confluency of ~70 %, and ~90 %, respectively. At day 3 cells were 
completely confluent.  
The expression of three different endothelial cell markers was checked: en-
dothelial nitric oxide synthase (eNOS), vascular endothelial-cadherin (VE-
cadherin) and van Willebrand factor (vWf). To confirm the genotype of pT Endo 
cells the expression of plectin was determined by anti-plectin antiserum #9. 
Additionally, caveolin-1 (caveolin) expression was checked since this protein is 
very abundant in ECs. Quantification of protein bands was determined by 
Quantiscan software (Fig. 6), described in Materials and Methods using tubulin 
as Quantiscan loading control. As expected plectin was only expressed in 
plectin+/+ pT Endo cells confirming the genotype of these cells (Fig. 6A). eNOS 
was expressed in both plectin+/+ and plectin-/- ECs but its levels were reduced 
in plectin-/- pT Endo cells. The effect appeared to be the strongest at day 1 in a 
subconfluent state of the cells (Fig. 6B).  
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Fig. 6. EC marker expression in pT Endo cells. Plectin+/+ and plectin-/- cells were lysed after 1, 
2 and 3 days of cultivation and analysed by immunoblotting using specific primary anti-
bodies and HRP-conjugated secondary antibodies. Tubulin: loading control (A). Statistic 
evaluation of eNOS (B), caveolin (C), VE-cadherin (D) and vWf (E). Blots were scanned 
and quantified by Quantiscan and standard deviation was calculated. Abbreviations: n: 
number of blots scanned. 
 
Similarly, caveolin levels were reduced in plectin-/- pT Endo cells, however, 
this effect did not depend on confluency state of cells (Fig 6C). VE-cadherin 
levels were reduced in plectin-/- pT Endo cells after day 1 and 2 of cultivation. 
However, when ECs reached a confluent state (day 3 of cultivation) the ex-
pression of VE-cadherin was more or less the same in both plectin+/+ plectin-/- 
ECs (Fig. 6D). To determine if plectin-/- ECs are expressing less of these EC 
markers because they are less pure than wildtype ECs, vWf expression was 
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checked. Equal amounts of vWf were found in both plectin+/+ and plectin-/- pT 
Endo cells (Fig. 6E). Taken together, these results confirm that plectin+/+ and 
plectin-/- pT Endo cells have the same purity and express EC markers, al-
though the total amounts of eNOS, caveolin and VE-cadherin are reduced in 
plectin-/- ECs.  
 
 
4.2. Generation of the endothelial cell line DH-1 
 
Since pT Endo cell lines were available only at higher passage numbers it was 
necessary to have another endothelial cell line. Cells were isolated from lungs 
of plectin+/+, plectin-/- and heterocygous plectin+/- mice of line 29 (Fig. 7). 
 
 
 
 
 
 
 
Fig. 7. Analysis of mouse genotype using plectin rod PCR. Lane 1: plectin-/-, 350 bp; Lane 2: 
plectin+/+, 950 bp; Lane 3: plectin+/-, 350 bp and 950 bp. 
 
When cells reached confluency they were immortalized by the middle T on-
cogene using a replication-defective selectable retrovirus (N-TKmT). Virus am-
plification was achieved in the safe packaging cell line (GP+E-86) stably trans-
fected with three plasmids. The gag and pol genes were on one plasmid 
(pGag-PolGpt) while the env gene was on the other (pEnv) (Fig. 9). The third 
plasmid contains a neomycin resistance gene (Δneo) and the polyoma middle 
T oncogen which expression is under the control of the thymidine kinase pro-
moter (Fig. 8) (Markowitz et al., 1988). It is still not exactly known why middle T 
antigene causes ECs proliferation and why specifically ECs gain proliferation 
advantage over other cells (Williams et al., 1988). 
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Fig. 8. Structure of retrovirus vector N-TK-mT. Symbols and abbreviations: neo, neomycin re-
sistance gene; LTR, long terminal repeat; TK, thymidine kinase promotor; mT, middle T 
gene; ψ, packaging signal sequence (Williams et al., 1988). 
 
 
 pGAG-Pol-gpT 
 
 
 pEnv 
 
Fig. 9. Structure of plasmids pgag-polgpt and penv. Symbols and abbreviations: thin lines, 
pBR322 sequences; ψ-, deletion of ψ packaging sequences; Ba, BamHI; E, EcoRI; Na, 
NaeI; S, ScaI (adapted from Markowitz et al., 1988). 
 
 
The presence of the neo gene in N-TKmT enabled the in vitro selection of 
cells containing the vector by addition of G-418 (neomycin homolog) to the 
medium. After 1 - 2 weeks of virus application, groups of ECs having cobble-
stone like morphology appeared while other cells died (Fig. 10). This typical EC 
morphology was also found in primary ECs cultures (Fig. 11). When ECs 
reached high density, cells were sorted by platelet-endothelial cell adhesion 
molecule -1 (PECAM-1). Since PECAM-1 is a cell surface molecule especially 
found on ECs (Gurubhagavatula I. et al., 1998), ECs of high purity were ob-
tained after this sorting step. This cell line was named DH-1. 
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Fig. 10. Phase-contrast images of DH-1 cells, at the beginning phases of immortalization (1 – 2 
weeks after virus infection) and after PECAM-1 sorting (passage 19). 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 11. Phase-contrast images of primary plectin+/+ and plectin-/- ECs. 
 
 
4.3. Characterization of DH-1 cell line 
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A detailed characterization of DH-1 cells was indispensable to confirm that 
these cells are indeed pure ECs. Expression of EC markers was checked us-
ing immunoblotting and immunofluorescence microscopy.  
Cells were lysed after 1, 2 and 3 days of cultivation and analysed using 
immunoblotting (Fig. 12). To further confirm the genotype of these cells plectin 
expression was determined by anti-plectin antiserum #9. As expected, plectin 
was only expressed in plectin+/+ ECs (Fig. 12A). DH-1 cells showed more or 
less the same expression pattern for eNOS, caveolin, VE-cadherin and vWf 
like pT Endo cells. eNOS and caveolin were expressed in both plectin+/+ and 
plectin-/- DH-1 cells but the levels were reduced in plectin-/- cells irrespectively 
from confluency state of the cells (Fig. 12B, C). VE-cadherin levels were re-
duced plectin-/- cells after the first two days of cultivation in a subconfluent state 
of the cells. However, when cells were completely confluent no difference in 
VE-cadherin expression between plectin+/+ and plectin-/- cells was detectable 
(Fig. 12D). Like in pT Endo cells equal amounts of vWf were found in both 
plectin+/+ and plectin-/- DH-1 cells (Fig. 12E).  
Taken together, these results confirm that plectin+/+ and plectin-/- DH-1 cells 
have the same purity and express all EC markers checked. Furthermore, DH-1 
cells had more or less the same expression pattern of EC markers as pT Endo 
cells.  
Next, DH-1 cells were fixed in a subconfluent state after 1 day of cultivation 
and immunofluorescently stained by specific antibodies.  
It was already observed that primary plectin-/- ECs express less VE-
cadherin and form less cell-cell contacts (Osmanagic-Myers, unpublished 
data). These data could be confirmed in DH-1 cells. In plectin+/+ DH-1 cells VE-
cadherin staining was more prominent and zipper-like structures more pro-
nounced compared to plectin-/- cells (Fig. 13). In mixed plectin+/+ and plectin-/- 
cultures, plectin-/- cells grown between plectin+/+ cells showed a more promi-
nent VE-cadherin staining (Fig. 14). Thus, plectin+/+ cells seemed to induce 
VE-cadherin cluster formation in neighboring plectin-/- cells. Immunofluores-
cence microscopy of eNOS was a punctuated and no accumulations were 
found at the cell periphery. eNOS  fluorescence signal was more intense in 
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plectin+/+ cells compared to plectin-/- cells, although the difference was not that 
drastic as observed in cell lysates (Fig. 15). 
 
Fig. 12. EC marker expression in DH-1 cells. Plectin+/+ and plectin-/- cells were lysed after 1, 2 
and 3 days of cultivation and analysed by immunoblotting using specific primary antibod-
ies and HRP-conjugated secondary antibodies. Tubulin: loading control (A). Statistic 
evaluation of eNOS (B), caveolin (C), VE-cadherin (D) and vWf (E). Blots were scanned 
and quantified by Quantiscan and standard deviation was calculated. Abbreviations: n: 
number of blots scanned. 
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Fig. 13. Immunofluorescence microscopy using anti-plectin antiserum #46 and mAb to VE-
cadherin in plectin+/+ and plectin-/- of DH-1 cells.  
 
Fig. 14. Immunofluorescence microscopy using anti-plectin antiserum #46 and mAb to VE-
cadherin of plectin+/+ and plectin-/- mixed cultures of DH-1 cells.  
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Fig. 15. Immunofluorescence microscopy using anti-plectin antiserum #46 and mAb to eNOS 
of plectin+/+ and plectin-/- mixed cultures of DH-1 cells.  
 
 
4.4. Plectin Isoform expression in endothelial cells 
 
Plectin isoform expression in pT Endo cells and DH-1 cells was checked by 
immunoblotting using specific plectin isoform antibodies. Plectin+/+ keratinocyte 
and plectin+/+ fibroblast lysates were used as positive controls for plectin iso-
forms 1a and 1c, and isoforms 1 and 1f, respectively. As shown in Fig. 16 DH-
1 and pT Endo cells express plectin isoforms 1a and 1.  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 16. Plectin isoform expression in DH-1 and pT Endo cells. Plectin+/+ and plectin-/- pT Endo 
(left column) and DH-1 (middle column) cells were lysed and analysed by immunoblot-
ting using specific plectin-isoform antibodies. Tubulin: loading control. 
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Since only four isoform-specific antibodies were available it would be nec-
essary to perform RNase protection assay to further check the expression of 
other isoforms in these cell lines. These data indicated that at least plectin iso-
forms 1a and 1 are expressed in plectin+/+ cells of both cell lines. Plectin iso-
forms 1c and 1f are not expressed in these cell lines (Fig. 16) 
 
 
4.5. Measurement of NO production 
 
It has already been shown that vimentin filament system of plectin-/- pT Endo is 
much more fragile to SNAP treatment in comparison to that of plectin+/+ pT 
Endo cells. Therefore, we wanted to check how plectin-/- cells cope with en-
dogenous levels of NO produced by eNOS. DAF-2 based extracellular NO 
measurement assay (see Material and Methods) was performed in cooperation 
with the group of Verena Dirsch at the Institute of Pharmacognosy (Vienna). 
Cells were either left untreated, treated with phorbol-12-myristate-13 acetate 
(PMA) to induce a maximum eNOS expression or treated with NG-monomethyl-
L-arginine (L-NAME) to completely inhibit eNOS activity.  
In NO production assay performed in pT Endo cells (Fig. 17A) the eNOS 
activity in untreated plectin+/+ pT Endo cells was set arbitrary to 100% increas-
ing after PMA treatment to 200 %. In plectin-/- pT Endo cells no eNOS activity 
was detected neither in untreated nor in PMA-treated cells. After treatment with 
eNOS inhibitor L-NAME eNOS activity was depleted in both cell types (Spurny 
et al., unpublished data). 
Both plectin+/+ and plectin-/- DH-1 cells produced NO, however, plectin-/- 
cells still produced less (∼10 %) in comparison to their wildtype counterparts 
(Fig. 17B). PMA treatment of plectin+/+ led to a potent increase of eNOS activity 
to 160 %, whereas in plectin-/- DH-1 cells only a slight increase to 98 % was 
detectable. Treatment with L-NAME led to complete depletion of NO produc-
tion in both cell types. 
NO production measurements were also performed with primary ECs (Fig. 
17C) isolated from kidneys and lungs of plectin+/+ and plectin-/- mice. Primary 
plectin-/- ECs isolated from kidneys showed a reduction in NO production in 
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comparison to plectin+/+ cells. In ECs isolated from lungs we observed a re-
versed phenotype, plectin+/+ ECs were producing less NO than plectin-/- ECs. It 
must be noted, however, that the results of primary ECs were not very reliable 
due to a very low efficiency of cell isolation. 
Together, these findings demonstrated that plectin-/- ECs produce less NO 
in comparison to plectin+/+ ECs. Furthermore, in contrast to strong eNOS acti-
vation observed in plectin+/+ ECs after PMA treatment only a negligible eNOS 
activation was observed in plectin-/- ECs.  
 
Fig. 17. Measurement of NO production in pT Endo cells n=3 (A), DH-1 cells n=2 (B) and pri-
mary ECs islolated from kidneys or lungs (C). Prior to measurement cells were either left 
untreated (control), treated with PMA or with L-NAME. 
 
 
4.6. Ser1177 and Thr495 Phosphorylation of eNOS 
 
To further investigate if reduced NO production in plectin-/- ECs is due to the 
fact that eNOS is less expressed in these cells immunoblotting using specific 
phospho-Thr495 and phospho-Ser1177 antibodies was performed. The activation 
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and inactivation status of eNOS were monitored with anti-phospho-Ser1177 and 
and anti-phospho-Thr495, respectively. 
eNOS protein levels (see also Fig. 6B and 12B) and activity (Fig. 17) were 
checked after 1, 2 and 3 days of cell cultivation. Later was particularly of inter-
est since at this day NO production was measured (see Fig.17). Tubulin was 
used as a loading control. 
As shown in Fig. 6A and 12A total eNOS amounts are reduced in plectin-/- 
ECs in comparison to plectin+/+ ECs after 1, 2, or 3 days of cultivation (Fig. 
18A).  
Fig. 18. eNOS phosphorylation status of plectin+/+ and plectin-/- DH-1 cells. Cells were lysed 
after 1, 2, or 3 days of cultivation and analysed by immunoblotting using specific antibod-
ies against eNOS, P-Ser1177, P-Thr495. Tubulin: loading control (A) Thr495 phosphorylation 
at the third day of cultivation calculated by Quantiscan software and plotted against 
eNOS values. n=2 (B) 
 
At day 1 and 2 no phospho-Ser1177 could be detected. Only at day 3 Ser1177 
phosphorylation of plectin+/+ and plectin-/- DH-1 cells was observed, however, 
slightly reduced in plectin-/- cells (Fig. 18A). At the first two days of cultivation 
specific-Thr495 phosphorlyation was reduced in plectin-/- cells in comparison to 
plectin+/+ cells. At day 3 specific Thr495 phosphorylation increased ∼ 15 % in 
plectin-/- DH-1 cells in comparison to plectin+/+ cells (Fig. 18B). Specific phos-
pho-Ser1177 eNOS was slightly decreased, whereas specific phospho-Thr495 
eNOS was significantly increased in plectin-/- compared to plectin+/+ ECs (Fig. 
18). Thus, this data indicated that plectin-/- DH-1 cells have reduced levels of 
total eNOS but also less active eNOS. 
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4.7. Cell fractionation of endothelial cells 
 
Caveolin, eNOS and VE-cadherin show different expression patterns in to-
tal lysates of plectin+/+ and plectin-/- pT Endo and DH-1 cells. To check if the 
localisation of these proteins is influenced by plectin deficiency digitonin-based 
cell fractionation experiments were performed in both cell types. Cell fractions 
were analysed by immunoblotting, scanned and quantified by Quantiscan soft-
ware (see Materials and Methods) followed by statistic evaluation (Tab. 8, 9). 
eNOS was found increased in the membrane fraction of plectin-/- com-
pared to plectin+/+ pT Endo cells, with a corresponding reduction in cytoskele-
ton fraction. A slight increase of eNOS in plectin-/- cells compared to plectin+/+ 
cells was also detected in the cytosolic fraction (Fig. 19A). Compared to 
plectin+/+ cells plectin-/- cells show drastic increase of caveolin in membrane 
fraction at the expense of the cytoskeleton fraction (Fig. 19B). Similar to caveo-
lin and eNOS, VE-cadherin was increased in membrane fraction and reduced 
in cytoskeleton fraction of plectin-/- compared to plectin+/+ pT Endo cells. In cy-
tosolic fractions no, or very low levels of VE-cadherin were detected (Fig. 19C).  
Cell fractionation experiments performed in DH-1 cells resulted in a more or 
less similar distribution of caveolin, eNOS and VE-cadherin compared to pT 
Endo cells. The protein levels were increased in membrane faction of plectin-/- 
cells compared to plectin+/+ cells with a corresponding reduction in cytoskele-
ton fraction (Fig. 20). It has to be noted that all of these proteins were found 
increased in the cytosolic fractions of both plectin+/+ and plectin-/- DH-1 cells, 
compared to pT Endo cells (compare Fig. 19 with Fig. 20).  
  fractions 
 plectin cytosol membrane cytoskeleton 
Caveolin + 2±3 33±4 65±1 
 - 1±0 75±14 24±9 
eNOS + 8±8 63±9 29±16 
 - 12±7 78±15 10±9 
VE-cadherin + 4±1 26±1 70±1 
 - 2±2 48±9 50±11 
Tab. 8. Mean values ± S. D. of cell fractionation experiments in pT Endo cells. 
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Fig. 19. Cell fractionation of pT Endo cells: Bar digrams showing cytosolic (black), membrane 
(white) and cytoskeleton (grey) fraction subjected to immunoblotting using specific 
antibodies against eNOS (A), caveolin (B), and VE-cadherin (C). Representative blot of 
cell fractions (D) (eNOS: membrane fraction longer exposed; VE-cadherin: same gel; 
caveolin: same gel; membrane fraction longer exposed; representative tubulin blot); 
Concentrations: cytosol: membrane: cytoskeleton= 8:8:1. Protein bands (n=5) were 
scanned and quantified by Quantiscan 
 
In conclusion the data obtained from cell fractionation experiments showed that 
caveolin, eNOS and VE-cadherin are found increased in membrane fractions 
and cytosoloic fractions of plectin-/- cells compared to plectin+/+ ECs, at the ex-
pense of the cytoskeleton fractions.  
 
  fractions 
 plectin cytosol membrane cytoskeleton 
Caveolin + 25±13 13±6 62±25 
 - 23±8 46±6 31±15 
eNOS + 20±9 24±16 56±16 
 - 21±9 55±1 24±11 
VE-cadherin + 19±7 43±9 38±5 
 - 23±4 59±5 17±9 
Tab.9. Mean values ± S. D. of cell fractionation experiments in DH-1 cells. 
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Fig. 20. Cell fractionation of DH-1 cells: Bar digrams showing cytosolic (black), membrane 
(white) and cytoskeleton (grey) fraction subjected to immunoblotting using specific anti-
bodies against eNOS (A), caveolin (B) and VE-cadherin (C). Representative blot of cell 
fractions (D) (eNOS: cytosolic and membrane fraction: same gel; VE-cadherin; cytosolic 
and membrane fraction: same gel; caveolin: cytosolic and cytoskeletal fraction from 
same gel; tubulin: representative blot; same gel as VE-cadherin). Concentrations: cyto-
sol: membrane: cytoskeleton= 4:2:1. Protein bands (n=4) were scanned and quantified 
by Quantiscan. 
 
 
4.8. Angiogenesis – Matrigel assay 
 
ECs play an essential role in angiogenesis. New blood capillaries are formed 
by sprouting from pre-existing ECs (Speidel, 1933). Matrigel, a basement 
membrane matrix, is a gelatinous protein mixture secreted by mouse tumor 
cells. It is known that cloned capillary ECs, cultured in tumour-conditioned me-
dium, form capillary tubes in vitro (Folkman et al., 1980). 
Tubing formation of DH-1 cells grown on matrigel for 6 h did not show any 
differences between plectin+/+ and plectin-/- cells (Fig. 21). This result would 
need further investigation at shorter growth time or under different conditions to 
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completely exclude the eventual role of plectin in tubing formation and angio-
genesis. 
 
Fig. 21. Phase-contrast images of plectin+/+ and plectin-/- DH-1 cells grown on matrigel. 
 
 
4.9. Effects of shear stress on plectin+/+ and plectin-/- endothe-
lial cells 
 
Functions of ECs are modulated by mechanical stimuli (like shear stress result-
ing from blood pressure and flow) that activate mechano-sensors on the cell 
membrane. These in turn activate different signalling pathways modulating the 
activation state and the expression of different proteins (Chien, 2006). Hemo-
dynamic forces lead to a reorientation of cells parallel to the direction of flow. 
All three cytoskeletal networks adapt their structure in response to shear 
stress: microtubules IFs elongate with the cell shape, whereas F-actin bundles 
disassemble, forming aligned stress fibers (Helmke, 2005). 
To determine eventual differences in the response of plectin+/+ and plectin-/- 
ECs to fluid shear stress flow experiments with a flow rate of 5 dynes/cm2 for 1, 
6 and 24 h were performed with both pT Endo and DH-1 cells. After exposure 
to fluid shear stress, cells were either fixed and immunofluorescently stained or 
lysed and analysed by immunoblotting. Effects of shear stress on eNOS, cave-
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olin, VE-cadherin, plectin and on all cytoskeletal filaments (microtubules, actin 
and vimentin) were investigated. 
 
 
4.9.1. Effects of shear stress on protein levels and localization of 
eNOS, vimentin and plectin 
 
Laminar shear affects endothelial NO production via activating eNOS within 
seconds and via increasing eNOS mRNA and protein levels within hours after 
initiation of flow stress (Harrison et. al, 2006).  
Immunoflurorescence microscopy of eNOS was diffuse and punctated in 
plectin+/+ and plectin-/- pT Endo and DH-1 cells under control conditions. In re-
sponse to laminar shear the staining became more prominent in plectin+/+ cells 
dependent on the duration of flow. Plectin-/- DH-1 cells showed reduced inten-
sity of eNOS compared to plectin+/+ cells irrespectively to duration of fluid shear 
stress (Fig. 22, 24).  
For better comparison of plectin+/+ and plectin-/- cells the eNOS signal in-
tensity in mixed plectin+/+ and plectin-/- DH-1 cultures were analysed. The stain-
ing was weak and punctated under no-flow conditions, however, being slightly 
more prominent in plectin+/+ cells. After 1 and 6 h of fluid shear stress the fluo-
rescence signal of eNOS became more intense in both plectin+/+ and plectin-/- 
cells dependent on the duration of fluid shear stress, but it was still less promi-
nent in plectin-/- DH-1 cells. The intensity for eNOS was higher in plectin+/+ 
cells, subjected to 6 h of flow than in cells subjected to 1 hour of fluid shear 
stress (Fig. 23). 
Taken together, these shear stress data revealed an eNOS up-regulation in 
both plectin+/+ pT Endo and plectin+/+ DH-1 cells but no up-regulation in plectin-
/- pT Endo cells and very slight up-regulation in plectin-/- DH-1 cells in response 
to 1, 6 and 24 h of fluid shear stress. 
As expected, no colocalization between eNOS and vimentin could be ob-
served under static. However, a slight colocalization was observed when 
eNOS signal became more intense in plectin+/+ cells under flow conditions. 
Under static conditions vimentin network of plectin+/+ DH-1 cells was more 
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compact and organized, whereas that of plectin-/- DH-1 cells was more flat-
tened and disorganized (Fig. 24A). In response to shear stress plectin+/+ 
vimentin network became flattened and cells tried to orientate in the direction 
of flow (Fig. 24C). Since cell density was very high, plectin+/+ cells did not 
manage to re-orientate completely (Fig. 24B, D). Shear stress did not seem to 
induce the re-orientation of plectin-/- DH-1 cells to flow (Fig. 24B, C, D). 
Vimentin network of plectin-/- DH-1 cells stayed more or less disorganized irre-
spectively to subjection to fluid shear stress. 
Similar changes of vimentin network were observed in pT Endo cells. How-
ever, more prominent disorganization of vimentin network was observed in 
plectin-/- pT Endo cells in comparison to plectin+/+ cells. Vimentin staining was 
filamentous in plectin+/+ pT Endo under static conditions. In plectin-/- pT Endo 
cells vimentin structure was star-like and progresses reached the cell periphery 
under no-flow conditions (Fig. 25A). Cell periphery could be nicely detected by 
VE-cadherin staining. Similar to DH-1 cells, vimentin staining of plectin+/+ pT 
Endo cells was more prominent and cells seemed to orientate in the direction 
of flow while the vimentin network of plectin-/- cells did not show drastic 
changes upon onset of fluid shear stress (Fig. 25B).  
Immunofluorescence microscopy of VE-cadherin cells showed a discon-
tinuous pattern at the cell periphery of plectin+/+ and plectin-/- pT Endo cells 
(Fig. 25A). After exposure to laminar shear the fluorescence signal for VE-
cadherin became more intense in plectin+/+ pT Endo cells, whereas a slight in-
crease was detectable in plectin-/- cells (Fig. 25B). 
Plectin is known to be up-regulated upon shear stress (Garcia-Carena et. 
al, 2001). Also in plectin+/+ pT Endo and DH-1 cells an increase of plectin ex-
pression was detectable after exposure to laminar shear for 1, 6 and 24 h (data 
not shown). The most significant increase of plectin was observed after 1 h of 
fluid shear stress (Fig. 23).  
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Fig. 22. Immunofluorecence microscopy of eNOS in plectin+/+ and plectin-/- pT Endo cells un-
der static conditions and after 1 h of fluid shear stress (5 dynes/cm2). Magnification x 63 
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Fig. 23. Immunofluorescence microscopy of eNOS and plectin in plectin+/+ and plectin-/- DH-1 
mixed cultures under static conditions, after 1 h and 6 h of fluid shear stress (5 
dynes/cm2). Magnification x 100 
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Fig. 24 A, B. Immunofluorecence microscopy of eNOS and vimentin in plectin+/+ and plectin-/- 
DH-1 cells under static conditions (A) and after 1 h (B), 6 h (C) and 24 h (D) of fluid 
shear stress. (5 dynes/cm2). Magnification x 63 
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Fig. 24 C, D. Immunofluorecence microscopy of eNOS and vimentin in plectin+/+ and plectin-/- 
DH-1 cells under static conditions (A) and after 1 h (B), 6 h (C) and 24 h (D) of fluid 
shear stress. (5 dynes/cm2). Magnification x 63 
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Fig. 25. Immunofluorecence microscopy of VE-cadherin and vimentin in plectin+/+ and plectin-/- 
pT Endo cells under static conditions (A) and after 1 h (B) of fluid shear stress 
(5dynes/cm2). Magnification x 63 
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4.9.2. Effects of shear stress on protein levels and localization of 
caveolin-1 and tubulin 
 
Exposure to shear stress affects caveolin localization and expression and in-
creases caveolae density. Flow-preconditioned cells expressed a fivefold in-
crease in caveolin compared to no-flow controls (Rizzo et. al, 2003).  
Immunofluorescence microscopy of the caveolar coat protein caveolin 
showed a punctate pattern in plectin+/+ and plectin-/- pT Endo and DH-1 cells 
under static conditions. However, the fluorescence signal for caveolin was 
more intense plectin+/+ pT Endo cells compared to plectin-/- cells. After expo-
sure to shear stress caveolin signal intensity increased in both plectin+/+ and 
plectin-/- pT Endo and DH-1 cells but was still reduced in plectin-/- cells (Fig. 26, 
27). 
After 1 hour of fluid shear stress a slight increase of caveolin signal inten-
sity in plectin+/+ and plectin-/- DH-1 cells was detected (Fig. 27B). After 6 and 24 
h caveolin staining was very intense in plectin+/+ DH-1 cells. Also in plectin-/- 
DH-1 cells an enhancement of the signal was observed, however, less promi-
nent compared to plectin+/+ DH-1 cells (Fig. 27C, D).  
These results showed a slightly reduced intensity for caveolin in plectin-/- 
compared to plectin+/+ cells in both pT Endo and DH-1 under static conditions. 
Upon onset of flow stress for 1, 6 and 24 h an up-regulation of caveolin was 
observed in both cell types although to less extent in plectin-/- cells.  
After 6 and 24 h of laminar shear stress a colocalization of tubulin and 
caveolin was observed in both plectin+/+ and plectin-/- cells, however, being 
more significant in plectin+/+ DH-1 cells (Fig. 27C, D). Between plectin+/+ and 
plectin-/- DH-1 cells no obvious difference concerning the microtuble network 
organization was observed. The tubulin staining in both plectin+/+ and plectin-/- 
DH-1 was showing a compact and aligned filamentous network under static 
conditions (Fig. 27A). After exposure to fluid shear stress for 1 and 6 h micro-
tubule network got flattened and widespread in both cell types (Fig. 27B, C). 
Upon 24 h of shear stress microtubule signal intensity slightly increased in both 
plectin+/+ and plectin-/- DH-1 cells (Fig. 27D).  
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Fig. 26. Immunoflurescence microscopy of caveolin-1 in plectin+/+ and plectin-/- pT Endo cells 
under static conditions and after 1 h of fluid shear stress (5 dynes/cm2). Magnification x 
63 
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Fig. 27 A,B. Immunoflurescence microscopy of caveolin-1 and tubulin in plectin+/+ and plectin-/- 
DH-1 cells under static conditions (A) and after 1h (B), 6h (C), and 24 h (D) of fluid shear 
stress (5 dynes/cm2). Magnification x 63 
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Fig. 27 C,D. Immunoflurescence microscopy of caveolin-1 and tubulin in plectin+/+ and plectin-/- 
DH-1 cells under static conditions (A) and after 1h (B), 6h (C), and 24 h (D) of fluid shear 
stress (5 dynes/cm2). Magnification x 63 
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4.9.3. Effects of shear stress on protein levels and localization of VE-
cadherin and actin 
 
In response to fluid shear stress VE-cadherin complexes undergo dynamic 
changes including a coordinated release and reattachment to the actin cy-
toskeleton (Ukropec et. al, 2002).  
As already observed in pT Endo cells, VE-cadherin staining of plectin+/+ and 
plectin-/- DH-1 cells was predominantly found at the cell periphery under no-
flow conditions. In plectin+/+ cells, patches of VE-cadherin, so called lattice-like 
structures were observed (Fig. 28A). Ukropec and colleagues observed lattice-
like VE-cadherin staining in ECs resulting from overlapping regions of mem-
branes on apposed cells under static conditions. After exposure to fluid shear 
stress the VE-cadherin staining at the cell borders became more intense in 
plectin+/+ DH-1 cells compared to plectin-/- cells (Fig. 28B). Upon 1, 6 and 24 h 
of laminar shear zipper-like character of VE-cadherin complexes became more 
prominent and increased upon longer exposure to flow in plectin+/+ DH-1 cells 
(Fig. 28B, C, D). After 24 h of fluid shear stress these structures were most 
pronounced in plectin+/+ cells (Fig. 28D). In plectin-/- DH-1 cells those zipper-
like structures were less prominent under all conditions (Fig. 28B, C, D).  
To confirm the different effect of fluid shear stress on VE-cadherin in 
plectin+/+ and plectin-/- DH-1 cells mixed cultures were subjected to fluid shear 
stress under absolute same conditions like confluency and shear stress rate. In 
mixed plectin+/+ and plectin-/- DH-1 cultures VE-cadherin was more prominent 
in plectin+/+ cells. Zipper-like structures were formed between neighboring cells 
under static conditions (Fig. 29). Upon onset of fluid shear stress VE-cadherin 
fluorescence signal became slightly more intense in both plectin+/+ and plectin-/- 
cells, zipper-like character of VE-cadherin complexes got more emphasized, 
however, being reduced in plectin-/- DH-1 cells (Fig. 29).  
Taken together, immunofluorescence microscopy of DH-1 and pT Endo 
cells showed slightly higher levels of VE-cadherin and much more zipper-like 
VE-cadherin clusters in plectin+/+ cells in comparison to plectin-/- cells after ex-
posure to flow stress. It has to be noted that under static conditions contrary 
results were observed. The effect was more pronounced in mixed cultures 
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where plectin-/- cells showed reduced levels of VE-cadherin, whereas plectin+/+ 
and plectin-/- cells showed equal VE-cadherin levels when cultured separately.  
Interestingly, co-staining of VE-cadherin and actin showed a nice colocali-
zation after exposure to fluid shear stress in plectin+/+ cells. Under static condi-
tions no or very little actin stress fibers were found in plectin+/+ and plectin-/- 
DH-1 cells. Since cells were completely confluent for at least 24 h before sub-
jected to flow stress actin staining was confined to cortical actin. It is known 
that in post-confluent cells stress fibers are becoming less prominent and a 
junctional dense peripheral band of F-actin is established (Noria et al., 2004). 
Cortical actin co-localized with lattice-like VE-cadherin patches in both 
plectin+/+ and plectin-/- DH-1 cells. Since much more of these patches were 
found in plectin+/+ cells this colocalization was more prominent in plectin+/+ DH-
1 cells (Fig. 28A). After exposure to fluid shear stress actin signal intensity be-
came stronger in both plectin+/+ and plectin-/- DH-1 cells. In plectin-/- DH-1 cells 
more actin stress fibers assembled increasing with the duration of fluid shear 
stress (Fig. 28B, C, D). However, the significant colocalization of cortical actin 
and VE-cadherin was only found in ple plectin+/+ cells and was most pro-
nounced after 6 and 24 h of laminar shear (Fig. 28C, D). Since co-staining of 
actin and VE-cadherin were only performed in DH-1 cells this phenotype could 
not be confirmed in pT Endo cells. 
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Fig. 28 A, B. Immunofluorecence microscopy of VE-cadherin and actin in plectin+/+ and plectin-/- 
DH-1 cells under static conditions (A) and after 1 h (B), 6 h (C) and 24 h (D) of fluid 
shear stress (5 dynes/cm2). Arrows indicating zipper- like VE-cadherin patches. Magnifi-
cation x 63.  
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Fig. 28 C, D. Immunofluorecence microscopy of VE-cadherin and actin in plectin+/+ and plectin-
/- DH-1 cells under static conditions (A) and after 1 h (B), 6 h (C) and 24 h (D) of fluid 
shear stress (5 dynes/cm2). Magnification x 63 
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Fig. 29. Immunofluorecence microscopy of VE-cadherin and plectin in plectin+/+ and plectin-/- 
DH-1 mixed cultures under static conditions and after 1 h of fluid shear stress (5 
dynes/cm2). Magnification x 100 
 
 
4.9.4. Effects of shear stress analyzed by immunoblotting 
 
After exposure to laminar shear stress, cells were lysed and protein expression 
was checked by immunoblotting using tubulin as loading control.  
eNOS expression was checked in lysates of both pT Endo and DH-1 cells. 
eNOS levels were higher in plectin+/+ pT Endo cells in comparison to plectin-/- 
cells under no-flow conditions. After exposure an up-regulation of eNOS pro-
tein levels was found in plectin+/+ cells but no or very little up-regulation was 
found in plectin-/- pT Endo cells (Fig. 30). These results confirm immunofluo-
rescence data of pT Endo cells (compare with Fig. 22). 
Lysates of flow-stressed DH-1 cells showed contrary results compared to 
immunofluorescence microscopy. These preliminary data revealed, as ex-
pected, reduced eNOS levels in plectin-/- DH-1 cells under static conditions 
(Fig. 31B).  
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Fig. 30. eNOS protein levels in pT Endo cells. Plectin+/+ and plectin-/- control and flow-stressed 
were lysed and analysed by immunoblotting using specific eNOS antibodies.  
 
However, upon 1 and 6 h of flow eNOS levels were up-regulated in 
plectin+/+ DH-1 cells. An up-regulation of eNOS was also twice observed in 
plectin-/- DH-1 cells after 1 hour of fluid shear stress (Fig. 31B). After 6 h of 
laminar shear eNOS levels did not change in shear-stressed plectin-/- cells in 
comparison to control plectin-/- cells. Due to the fact that there was no tubulin 
as a loading control it is very difficult to analyze these blots and make a definite 
statement. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 31. Caveolin (A), eNOS (B) and VE-cadherin (C) protein levels in DH-1 cells. Plectin+/+ and 
plectin-/- control and flow-stressed DH-1 cells were lysed and analysed using monoclonal 
antibodies. 
 
Lysates of control and flow-stressed cells analyzed by immunoblotting 
showed that caveolin expression was slightly reduced in plectin-/- DH-1 cells in 
comparison to plectin+/+ DH-1 cells under static conditions. After exposure to 
fluid shear stress for 1 hour caveolin was up-regulated in both plectin+/+ and 
plectin-/- DH-1 cells confirming results from immunofluorescence microscopy 
(compare with Fig. 27). After 6 h of laminar shear immunoblotting revealed a 
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higher up-regulation of caveolin levels in plectin-/- cells in comparison to 
plectin+/+ DH-1 cells (Fig. 31A).  
Cell lysates, obtained from control and flow-stressed cells were tested for 
VE-cadherin expression using immunoblotting. Lysates from DH-1 cells 
showed more or less equal levels of VE-cadherin in plectin+/+ and plectin-/- un-
der static conditions. Upon onset of fluid shear stress higher levels of VE-
cadherin were found in both plectin-/- and plectin+/+ DH-1 cells (Fig. 31C). 
These data supported immunofluorescence data of mixed plectin+/+ and plectin-
/- cells that revealed no or very slight differences in the protein levels of VE-
cadherin. Immunoblots of lysates from pT Endo cells revealed contrary results. 
In pT Endo cells no or only slight differences of VE-cadherin expression were 
detected under static conditions and after exposure to fluid shear stress (Fig. 
32).  
 
 
 
 
 
 
Fig. 32. VE-cadherin protein levels in pT Endo cells. Plectin+/+ and plectin-/- control and flow-
stressed pT Endo cells were lysed and analysed by immunoblotting using specific VE-
cadherin and tubulin antibodies.  
 
Taken together, the results did not completely confirm that eNOS was up-
regulated in plectin+/+ but not in plectin-/- pT Endo and DH-1 cells after expo-
sure to fluid shear stress. VE-cadherin up-regulation in pT Endo and DH-1 cells 
in response to fluid shear stress could not be confirmed. Furthermore, im-
munoblotting revealed an up-regulation of caveolin in both plectin+/+ and 
plectin-/- DH-1 cells after 1 hour of shear stress, reinforcing the immunofluoer-
scence data.  
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5. Discussion 
 
 
ECs form the permeable barrier between the blood and the vessel wall and 
play a role in cell remodelling, migration, apoptosis, and proliferation. Further-
more, ECs control the vascular homeostasis by secreting biochemical sub-
stances like NO, ROS or glutathione. The flow of blood results in mechanical 
stresses acting on the vessel wall influencing EC structure, growth and func-
tions. Cell membrane proteins, ion-channels, caveolae and alterations of the 
cellular cytoskeleton are candidates for mechanosensors in ECs that sense 
changes in fluid shear stress (Fisher et al., 2001). Due to plectin’s subcellular 
distribution and the vast variety of its binding partners plectin is supposed to be 
a scaffolding platform for signalling molecules. These facts let us suggest that 
plectin might play a role in sensing and / or responding to fluid shear stress in 
ECs. In this thesis the role of plectin in two different endothelial cell lines, pT 
Endo and DH-1, was investigated. Immunofluorescence microscopy and im-
munoblotting of cell lysates revealed that these cell lines expressed endothelial 
specific markers eNOS, van Willebrand factor and VE-cadherin.  
eNOS is localized within plasma membrane invaginations called caveolae 
and the Golgi apparatus. In response to cell stimulation eNOS is shuttling be-
tween different intracellular compartments (see review Fleming and Busse, 
2003). Although eNOS was detected in the cytosol and in association with the 
cytoskeletal cell fraction in some ECs the intracellular localization of this en-
zyme is still controversial. Immunoblottings showed that total levels of eNOS 
were reduced in plectin-/- ECs in comparison to plectin+/+ cells. Cell fractiona-
tion experiments revealed an increase of the membrane fraction of eNOS in 
plectin-/- compared to plectin+/+ pT Endo and DH-1 cells, with a corresponding 
reduction in the cytoskeleton fraction. These findings suggest an association of 
eNOS with the cytoskeleton via plectin as a linker. It is therefore conceivable 
that in the absence of plectin an accumulation of eNOS occurs at the cell pe-
riphery due to the lack of its cytoskeletal docking site. This mislocalization 
might in turn lead to increased eNOS degradation and thus to reduced total 
levels of this protein in the absence of plectin.  
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Altered localization and reduced levels of eNOS in plectin-/- ECs might af-
fect the activity of the enzyme and thus NO production. Indeed, DAF-based 
assays (Räthel et al., 2003) showed that the amounts of NO produced in un-
treated and PMA-stimulated DH-1 cells were reduced in plectin-/- cells com-
pared to plectin+/+ cells. An inhibitor of eNOS, L-NAME, (Hibbs et al., 1987) led 
to a complete depletion of NO production in both cell types. These results are 
consistent with the observations obtained in plectin-/- pT cells (Spurny, 2006). It 
must be noted, however that already in untreated state a reduction in NO pro-
duction was observed in pT Endo cells. This might be due to a high passage 
number at which pT Endo were used. Prolonged PMA incubation used in this 
assay most probably acts in two ways. First, it is known that it leads to an en-
hanced eNOS expression (Huige et al., 1997; Shu-Ching et al., 1999). Second, 
it enhances eNOS activity by causing a down-regulation of protein kinase C 
(PKC). Down-regulation of PKC most likely further activates eNOS since PKC 
phosphorylates Thr495 (Michell et al., 2001) known as a negative regulatory site 
of eNOS (see review Fleming and Busse, 2003). Plectin might also directly in-
fluence PKC since it is known, however, from another cell system that the ac-
tivity of PKCδ is strongly elevated in plectin-/- fibroblasts (Osmanagic-Myers 
and Wiche, 2004). Since PKC inhibits eNOS activity by Thr495 phosphorylation 
the reduced eNOS activity in plectin-/- ECs might be caused by a stronger PKC 
signalling. It has been shown that some PKC family members (PKCα, PCKε) 
can phosphorylate eNOS also at Ser1177 (Partovian et al., 2005; Zhang et. al., 
2004) supporting the theory that down-regulated PKC signalling reduces eNOS 
activity in plectin-/- ECs.  
In addition to Thr495 another major phosphorylation site through which 
eNOS activity is regulated by is Ser1177. Multiple stimuli like shear stress, es-
trogen or insulin activate Akt-kinase and cAMP-dependent protein kinase 
(PKA) that phosphorylate Ser1177 which leads to a two- to threefold increase of 
NO production. Immunoblotting using specific antibodies against phospho-
Thr497 and phospho-Ser1177 eNOS showed a significantly higher phospho-
Thr497-specific signal eNOS and a slightly lower phospho-Ser1177-specific signal 
in plectin-/- cells compared to plectin+/+ ECs. Thus, both assays implicate re-
duced activity of eNOS in plectin-/- cells in comparison to plectin+/+ cells. 
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Shear stress can potently activate eNOS enzyme by increasing intracellu-
lar calcium leading to Ser1177 phosphorylation of eNOS within seconds. Pro-
longed exposure to fluid shear stress leads to an increase of eNOS mRNA and 
protein levels depending on cSrc-kinase and a MAP-kinase pathway involving 
Ras, Raf, MEK and Erk 1/2 (Harrison et al., 2006). After 1h of shear stress 
eNOS expression remains elevated, due to prolonged stabilization of eNOS 
mRNA mediated by cSrc-kinase (Harrison et al., 2006). Exposure to shear 
stress of plectin+/+ and plectin-/- DH-1 and pT Endo cells revealed an up-
regulation of eNOS plectin+/+ but no or only a slight increase in plectin-/- cells. 
The reduced responsiveness of plectin-/- cells to shear stress stimuli regarding 
eNOS up-regulation might be due to several reasons: (i) Mislocalization of 
eNOS due to the lack of plectin as a cytoskeletal docking site; (ii) Significant 
differences of the actin filament system in plectin+/+ and plectin-/- ECs in re-
sponse to shear stress. Whereas, in plectin+/+ cells shear stress induced the 
accumulation of cortical F-actin associated with adherens junctions, in plectin-/- 
DH-1 cells stress fibers predominated, especially after prolonged flow expo-
sure. Su and colleagues found a co-localization of eNOS and actin within 
caveolae. Furthermore, they observed that a disruption of the actin filament 
network led to an increase in eNOS activity (Su et al., 2003). Hence, stress fi-
bers might hinder eNOS in its activation. (iii) Elevated PKC signalling in plectin-
/- cells as already mentioned above.  
It has already been shown that eNOS localize in plasmalemmal caveolae 
(Garcia-Cardena et al., 1996). A variety of signalling molecules are concen-
trated within these flask-shaped structures present on the membrane among 
them is caveolin-1, the major coat protein of caveolae (Gratton et al, 2004). 
Caveolae have also been proposed to be shear stress mechanosensors in 
ECs (Fisher et al., 2001). Surprisingly, we found reduced levels of caveolin-1 in 
plectin-/- ECs compared to plectin+/+ cells. Furthermore, a drastic increase of 
caveolin-1 in membrane fraction at the expense of the cytoskeleton fraction 
was observed in plectin-/- cells compared to plectin+/+ cells using cell fractiona-
tion experiments. Mundi and co-workers proposed that the caveolar membrane 
system consists of three caveolin-1-containing compartments. These include 
caveolae that are kept at the cell surface by actin filaments, the peri-
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centrosomal caveosomes and caveolar vesicles that move constitutively and 
bi-directionally along microtubules between the cell surface and caveosomes 
(Mundi et al., 2002). From the literature little is known about a connection be-
tween caveolin and IFs and their role in caveolin trafficking and localisation. 
Since plectin is an important IF-binding protein (Wiche and Baker, 1982) it is 
conceivable that the IF connection is impaired in plectin-/- ECs. We suggest 
that caveolin-1 is bound via plectin to the cytoskeleton. It remains to be investi-
gated whether plectin connects caveolin with actin, microtubules or IFs. In the 
absence of plectin, the link between caveolin and the cytoskeleton might be 
abolished and caveolin therefore translocated to the membrane. Again, similar 
to eNOS, altered localization might lead to partial degradation of excess caveo-
lin and thus reduced levels of this protein in the absence of plectin. 
Exposure to shear stress increases caveolae density and alters cavoelin 
expression and distribution. Furthermore, caveolar-residing proteins like eNOS, 
caveolin-1 or mitogen-activated kinases (Erk 1/2) are significantly up-regulated 
in response to fluid shear stress (Rizzo et al., 2002). We observed an up-
regulation of caveolin in response to fluid shear stress in plectin+/+ and plectin-/- 
cells although caveolin levels were still reduced in plectin-/- cells. 
Based on the results obtained, the following working model can be pro-
posed: In plectin-/- cells eNOS and caveolin accumulate at the membrane with 
a corresponding reduction in the cytoskeleton. This suggests that plectin either 
directly or indirectly is sequestering both proteins to the cytoskeleton. It is 
known that the putative caveolin scaffolding domain (amino acids 82 – 101) in 
caveolin-1 inhibits eNOS activity by reducing NADPH-dependent electron flux 
from its reductase to the oxygenase domain, thereby reducing NO release from 
cells (Gratton et al., 2004). A surplus of both proteins at the membrane fraction 
of plectin-/- cells might result in an enhanced inhibition of eNOS caused by the 
stronger interaction with caveolin. This would fit to our findings that eNOS ac-
tivity and NO production were reduced in plectin-/- cells in comparison to 
plectin+/+ ECs. 
Plectin-/- mice die on the second day after birth developing large blisters of-
ten accompanied by bleedings, particularly at their extremities (Andrä et al., 
1997). This type of bleeding might indicate a possible perturbation of the vas-
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cular system. The establishment of monolayer integrity is regulated by VE-
cadherin, a unique member of the cadherin family, specifically expressed in 
ECs (Venkiteswaran et al., 2001). VE-cadherin is known to play a role in adhe-
sion of ECs and regulation of their growth, survival, migration and proliferation 
(Venkiteswaran et al., 2001). VE-cadherin deficient embryos develop severe 
vascular defects and die at day 11,5 of embryonic development. (Carmeliet 
and Collen, 2000). ECs from these embryos show increased apoptosis, due to 
an inability of VE-cadherin-deficient cells to respond to the survival signal of 
vascular endothelial growth factor (VEGF) (Carmeliet and Collen, 2000). 
In comparison to plectin+/+ cells, plectin-/- ECs showed a down-regulation of 
VE-cadherin on the first two days of cultivation as revealed by immunoblottings 
of the corresponding lysates. When cells became confluent the levels of VE-
cadherin were equal. Cell fractionation experiments revealed an increase of 
VE-cadherin in membrane fraction at the expense of the cytoskeleton in 
plectin-/- cells compared to plectin+/+ cells. Furthermore, by immunofluores-
cence microscopy, more zipper-like VE-cadherin structures were observed in 
subconfluent plectin+/+ cultures in comparison to plectin-/- cultures (Osmanagic-
Myers, unpublished data). Ukropec and colleagues proposed that these zipper-
like structures result from overlapping regions of membranes on apposed ECs 
(Ukropec et al., 2002). These findings and the fact that VE-cadherin and plectin 
co-localized at the immunofluorescent level (Osmanagic-Myers, unpublished 
data) suggest a role of plectin in regulating VE-cadherin function. The absence 
of plectin might lead to a discontinuous border of loosely connected ECs. 
Upon onset of shear stress the intracellular cadherin complexes seemed to 
broaden and stain more intensively (Ukropec et al., 2002). In response to fluid 
shear stress we observed an increase of VE-cadherin expression and cluster-
ing in both cell types, but cluster formation and expression levels seemed re-
duced in plectin-/- cells. The zipper-like character of VE-cadherin complexes in 
plectin+/+ was most pronounced after 6 and 24 hours of fluid shear stress. In 
plectin+/+ cells these structures coincided nicely with more pronounced cortical 
actin compared to plectin-/- cells implicating increased contractility of plectin+/+ 
cells. For this reason, it would be conceivable that plectin+/+ cells are able to 
withstand higher shear stress forces compared to plectin-/- cells. Thus, shear 
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stress induced changes of ECs junctions might have important implications for 
the control of the endothelial permeability barrier and other aspects of endothe-
lial cell function. Since cluster formation and VE-cadherin levels were reduced 
in plectin-/- ECs the endothelial barrier function might be impaired in these 
cells.  
Shear stress leads to a re-orientation of the cell parallel to the direction of 
flow. All three cytoskeletal networks adapt their structure in response to hemo-
dynamic forces (Helmke, 2005). After exposure to laminar shear stress 
vimentin filaments are known to elongate and re-orientate parallel to the direc-
tion of flow (Garcia-Cardena et al., 2001). Under static conditions a more dis-
organized vimentin network was observed in plectin-/- ECs compared to 
plectin+/+ cells. In response to shear stress plectin+/+ ECs appeared as if trying 
to re-orientate in the direction of fluid shear stress, although DH-1 cells did not 
manage to re-orientate completely. However, the vimentin network of plectin-/- 
pT Endo and DH-1 cells did not show drastic changes. This might be due to 
the fact that very modest flow-related cytoskeletal reorientations occur in post-
confluent cultures (Noria et al., 2004). Furthermore, the rate of cytoskeletal re-
modelling is significantly slowed in cells grown on gelatine (Helmke, 2005). 
 
Taken together these results show the important role of plectin in regulat-
ing EC functions. It will be interesting to explore in more detail the exact 
mechanism by which plectin influences eNOS activity. Further studies involving 
the characterization of the endothelium-specific plectin deficient mice might 
open interesting aspects of plectin’s potential role in the development of typical 
vascular diseases, such as atherosclerosis, vascular dilation, and aneurysm or 
hypertension. 
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